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Introduction 
 Habit is a pattern of behavior acquired through frequent repetition. 
Habits can be beneficial or deleterious in nature. Tobacco usage, alcohol intake 
or combinations of both are examples of deleterious habits. These preventable 
habits are associated with significant morbidity and mortality. The population 
should be aware of the potential consequences of prolonged exposure to tobacco 
and alcohol 147. 
Tobacco use, including smoking of cigarettes, cigars and pipes, reverse 
smoking (smoking with the lit end inside the mouth), chewing of betel quid (a 
mixture of areca nut, slaked lime, and tobacco wrapped in betel leaf), and use of 
smokeless tobacco increases the risk of cancers of the upper aerodigestive tract 
27, 42. Tobacco usage is, together with drinking alcohol, the major risk factor for 
oral cancer. 
Oral cancer is dominated by squamous cell carcinoma (present in 90%-
95% of all oral cancers), and the role of tobacco in the development of oral 
squamous cell carcinoma is well recognized. The long-term prognosis is quite 
poor, and treatment can lead to further functional and cosmetic problems 104, 105.  
Based on population-based case-control studies, cigarette smokers have 
risk of two to five times than that of non-smokers for developing oral cancer. 
The risks increase with the numbers of cigarettes smoked and the duration of 
smoking. Tobacco-specific N-nitrosamines, aromatic amines, and polycyclic 
aromatic hydrocarbons present in mainstream tobacco smoke are considered 
as the major carcinogens 103. 
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Although epidemiologic studies consistently report that, risk of oral 
cancer declines with the number of years of abstinence from cigarettes, it can 
take many years for the risks to reach those of non-smokers.  
Studies have also demonstrated that drinking alcoholic beverages is 
associated with the development of cancers in the oral cavity 106. When ethanol 
is consumed through drinking, it is metabolized primarily by class I alcohol 
dehydrogenase (ADH2) into acetaldehyde, an intermediate metabolite, and then 
it is metabolized by aldehyde dehydrogenase (ALDH2) into acetic acid in 
humans 107. Acetaldehyde, a well-known carcinogen in animals, plays an 
important role in alcohol toxicity in humans 108. 
Heavy smokers who drink alcohol heavily have an increased risk of 
developing oral cancer than that expected from the independent effects of 
smoking and alcohol intake 147. 
Smokeless tobacco, in the forms of chewing tobacco and snuff, is also 
linked to oral cancer. Tobacco is chewed predominantly as an ingredient of 
betel quid or pan, which is a combination of betel leaf, areca nut, and lime. 
Based on analysis that excluded smokers, smokeless tobacco users experienced 
about four to six times the risk of oral and pharyngeal cancer than non-users. 
Nitrosamines are produced at relatively high levels during fermenting and 
curing and these products have an etiological role 104, 105.  
Premalignant lesions of the oral cavity represent an important target for 
cancer prevention. The two most important lesions are leukoplakia and sub-
mucous fibrosis. 
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These lesions represent clinical rather than histological diagnoses, but 
their importance derives from the high proportion of cases in which biopsy 
reveals dysplasia or even frank carcinoma. These lesions can be detected by 
visual inspection and are amenable for large-scale screening efforts.  
 Oral leukoplakia is currently defined as a predominantly white lesion of 
the oral mucosa that cannot be characterized as any other definable lesion; 
some of these lesions will develop into cancer.  The recent classification and 
staging system also incorporates provisional and definitive diagnoses on the 
basis of histopathological features of persistent lesions lasting longer than 2 to 4 
weeks, such as the size of the leukoplakia and the presence of epithelial 
dysplasia. There is a significant correlation between the incidence of 
leukoplakia and smoking 109. 
Smokers with oral premalignant lesions such as leukoplakia have an 
annual cancer transformation rate of about 5% 110. A case-control study, 
conducted by Shiu et al in Taiwan, showed that the adjusted ratio for betel nut 
chewing and smoking on the occurrence of leukoplakia were 17.43 and 3.22, 
respectively. The findings suggested that stopping smoking may reduce the 
number of leukoplakia cases by 36%, while elimination of betel nut and tobacco 
influence may prevent 62% cases of leukoplakia and 26% of cases of malignant 
transformation to oral carcinoma 111.  
In the Indian scenario, the proportion attributed to tobacco use in the 
form of smoking and chewing comprises about 61-70% of cancer incidence. 
Among Indians, alcohol drinking does not emerge as a strong risk factor 115. 
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Sub-mucous fibrosis is a pre-cancerous condition, predominantly 
affecting buccal mucosa, retromolar area and the soft palate. Recently, an 
increased incidence of malignancy is noted in oral submucous fibrosis patients, 
particularly in people who use commercially available products. The malignant 
transformation of betel quid users in India is around 8%, which is quite high 115, 
145. 
 There is increasing evidence that sub-epithelial connective tissue can 
modify the phenotypic expression of the overlying epithelium. Various tissue 
culture studies suggest that the histo-differentiation of the epithelium, including 
its phenotype and keratin expression could be extrinsically modified by 
mesenchymal fibroblasts 112, 113, 114. We could elucidate that the underlying 
connective tissue plays a pivotal role in the maintaining the integrity of 
overlying epithelium.  
Therefore, a study was designed with varying parameters and tools to 
evaluate the stromal changes in apparently normal oral mucosa of patients 
with or without deleterious habits. The stromal changes were then compared 
with leukoplakia, oral sub-mucous fibrosis, well differentiated squamous cell 
carcinoma, moderately differentiated squamous cell carcinoma and verrucous 
carcinoma. 
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AIMS AND OBJECTIVES 
1. To compare and contrast the various changes in the connective tissue among 
patients with the habits of smoking (n=10), pan chewing (n=10) and 
Controls (n=10) by using fluorescence spectroscopy. 
2. To evaluate the connective  tissue changes in patients with the habits of 
Smoking (n=5)  and Pan chewing (n=5)  in comparison with  Controls (n=5), 
by using histo-pathological stains namely, 
a. Hematoxylin and Eosin stain 
b. Van Gieson stain 
3. To evaluate and compare these groups, among patients with Leukoplakia (n 
= 5), Sub mucous fibrosis (n=5), Well-differentiated squamous cell 
carcinoma (n=5), Moderately differentiated squamous cell carcinoma (n=5) 
and Verrucous carcinoma (n=5), by using histo-pathological stains namely, 
a. Hematoxylin and Eosin stain 
b. Van Gieson stain 
4. To evaluate the changes in fibroblasts in patients (n=5) with habits of 
smoking (n=2) and pan chewing (n=2) and a control (n=1), by Transmission 
electron microscopy. 
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Review of Literature 
Most malignancies of the upper aerodigestive tract are squamous cell 
carcinomas (SCC) arising in the mucous membranes of the mouth, pharynx, 
and larynx and share common risk factors. Of all oropharyngeal malignancies 
reported to the SEER registries in the United States between 1973 and 1987, 
apart from lesions of salivary glands, gingivae, nasopharynx, nasal cavity, and 
sinuses, more than 95 percent were SCC.1 
For both genders combined, cancer of the mouth and pharynx ranks sixth 
overall in the world, behind lung, stomach, breast, colon and rectum, and cervix 
plus corpus uteri. Cancer of mouth and pharynx is the third most common site 
among males in developing countries and fourth among females. The highest 
rates in the world for oral cancer are found in France, the Indian subcontinent, 
Brazil, and central/eastern Europe 1. 
Incidence increases with age in all countries. In the West, 98 percent of 
oral and pharyngeal cases are in patients over forty years of age. In high-
prevalence areas, cases occur prior to the age of thirty-five due to heavy abuse 
of various forms of tobacco. 
Furthermore, a number of cases of oral mucosal SCC occur in both young 
and old patients often in the absence of traditional alcohol and tobacco risk 
factors and may pursue a particularly aggressive course.70 
In industrialized countries, men are affected two to three times as often 
as women, largely due to their higher indulgence of alcohol and tobacco for 
intra-oral and laryngeal cancer and higher exposure to sunlight for lip cancer 
among those who work outdoors. However, the incidence of tongue and other 
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intra-oral cancer for women can be greater than or equal to that for men in 
high incidence areas such as India, where chewing and sometimes smoking are 
also common among women. 
Emigrants from high-incidence regions to other parts of the world result 
in comparatively high rates in immigrant communities. Among Indians in the 
Malay Peninsular, for example, oral cancer has long been considerably more 
common than among Malays or Chinese.71 Similar trends are noted among 
Indian migrants from India to Natal.72 
Taken together, the effects of tobacco use, heavy alcohol consumption, 
and poor diet probably explain over 90 percent of cases of head and neck 
cancer. The vast majority of individuals who develop squamous cell carcinoma 
of the upper aerodigestive tract have a history of smoking tobacco3. Many of 
these individuals also consume alcohol regularly4, 5. The increased risk for 
developing head and neck cancer in these individuals has been well established 
by large epidemiological studies.4–10  
Among men in industrialized countries, smoking is estimated to be the 
cause of 40-45 percent of all cancer deaths, 90-95 percent of lung cancer deaths, 
over 85 percent of oral cancer deaths, 75 percent of chronic obstructive lung 
disease deaths, and 35 percent of cardio-vascular disease deaths in those aged 
thity-five to sixty-nine years. Alcohol synergizes with tobacco as a risk factor for 
all upper aerodigestive tract SCC: this is super-multiplicative for the mouth.27 
 Smoking of tobacco as factory-made cigarettes, cigars and cheroots, and 
loose tobacco in pipes or hand-made cigarettes is familiar to all. Tar, nicotine, 
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and nitrosamine content vary greatly, depending on species, curing additives, 
and method of combustion. 
Such smoking habits are the predominant form of tobacco use in the West 
and among increasing millions in developing countries.  
Not only have the smoking of tobacco and the drinking of alcohol each 
been demonstrated to be independent risk factors for the development of head 
and neck cancer, but together they have been shown to increase patient cancer 
risk in a multiplicative manner.5–7  
The potentiation of the carcinogenic effects of tobacco by alcohol may be 
a consequence of its solvent properties or its toxicity to the respiratory epithelial 
enzyme systems.11, 12 Alcohol is also able to induce hepatic microsomal enzymes 
that are capable of transforming proximate carcinogens to ultimate 
carcinogens.11, 12  
Other factors that are believed to contribute to the carcinogenic effect of 
alcohol include nutritional deficiencies that occur in heavy drinkers and 
contaminants and congeners that are present in alcohol.11, 12. Unfortunately, 
smoking and drinking are social behaviors that commonly occur together, with 
smokers being drinkers and vice versa.5 
Most oral cavity cancers (75%) are located in a horseshoe-shaped area 
that extends from the anterior floor of the mouth and includes the tonsillar 
pillar/retromolar trigone complex. It has been suggested that concentrated 
carcinogens suspended in saliva are pooled in these areas, encouraging 
carcinogenesis.13. Although the hard palate, buccal mucosa, gingiva, and tongue 
were once considered common sites for squamous cell carcinoma, studies have 
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demonstrated that three specific intraoral areas are most predisposed to 
develop squamous cell carcinoma in drinkers and smokers 167, 168. The floor of 
the mouth, ventrolateral tongue, and soft palate complex (soft palate proper, 
lingual aspect of the retromolar trigone, and anterior tonsillar pillars) should 
be regarded as high-risk sites.  
The site and size of 222 asymptomatic squamous cell carcinomas were 
documented in 161 cigarette smokers who were also drinkers. Of 207 intraoral 
lesions (excluding 15 of the lip), 201 lesions (97 percent) were found in three 
locations: 101 (50 percent) in the floor of the mouth, 64 (32 percent) in the soft 
palate complex and 36 (18 percent) in the ventral or lateral tongue.167 
 Examination of the anatomical sites predisposed to manifesting head and 
neck cancers have demonstrated that the risks of developing oral, pharyngeal, 
and laryngeal cancers are especially high in individuals who both smoke 
tobacco and drink alcohol.7– 10, 12, 14 
Role of Smokeless Tobacco: 
Much of the tobacco in the world is consumed without combustion. 
Rather, it is placed in contact with mucous membranes, through which nicotine 
is absorbed to provide the pharmacological effect. Use of nasal stuff, popular in 
the last century, is returning. 
Other forms of snuff, loose or in packets and placed in the oral vestibule, 
are common in Scandinavia and United States. 
Tobacco is also prepared in blocks or flakes for chewing. In developing 
countries, tobacco is mostly consumed mixed with other ingredients. The very 
extensive evidence for carcinogenicity of these mixtures is covered exhaustively 
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in Daftary et al28 and Gupta et al.29 .Toombak, the form used in Sudan, contains 
very high levels of tobacco specific nitrosamines (TSNs), and users show 
significantly increased risks of oral squamous cell carcinoma.30 
Role of Betel Quid: 
Quid should be defined as “a substance, or mixture of substances, placed 
in the mouth or chewed and remaining in contact with the mucosa, usually 
containing one or both of the two basic ingredients, tobacco or areca nut, in raw 
or any manufactured or processed form”. Thus betel quid is to be considered as 
a specific variety of quid: it indicates any type of mixture or quid that included 
betel leaf. 
Quid can be categorized into three forms namely, 
• Quid with areca nut but without tobacco products (Areca nut quid) 
o Chewing areca nut only 
o Chewing betel leaf and areca nut 
• Quid with tobacco products but without areca nut (Tobacco quid) 
o Chewing tobacco 
o Chewing tobacco and lime 
o Use of mishri (burned tobacco applied to teeth and gums) 
o Use of niswar (a type of tobacco snuff) 
o Use of naas (a stronger brand of niswar) 
o Moist snuff 
o Dry snuff 
• Quid with areca nut as well as tobacco products (Tobacco and 
Areca nut quid) 
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o Betel quid with tobacco 
o Betel with tobacco-lime-areca nut mixtures 
o May contain tobacco leaves (whole or crushed), packaged 
tobacco products like zarda, gutkha  
Quids are prepared from areca nut, cured or sun-dried, and chopped, 
then usually placed on a leaf of the Piper betel vine. Slaked lime is an essential 
ingredient. It lowers pH and accelerates release of alkaloids from both tobacco 
and nut, with enhanced pharmacological effect. 
Daftary et al 31 has reported the evidence for carcinogenicity of betel quid 
and the important role of tobacco in considerable detail. 
Role of Areca Nut Alone: 
Although the IARC32 concluded that there was insufficient evidence that 
the chewing of betel quid without tobacco was carcinogenic to man, this is a 
probability. Areca nut is certainly the main etiological agent in oral submucous 
fibrosis33 but in this case-control study twelve of the fourteen concurrent oral 
cancer and submucous fibrosis patients also used tobacco. 
In Guam, where areca nut is chewed alone or with leaf only, there is 
apparently no increase in oral cancer34. Conversely in Taiwan, most heavy 
chewers of betel quid do not include tobacco, yet oral cancer is clearly 
associated.35  
As we evaluate the dangers of these complex mixtures, it is important to 
remember that betel leaf is also protective in nature 36 and at least two 
compounds have been identified: carotene and hyroxychavicol, an astringent 
antiseptic. 
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Brown et al 37 described “snuff-dipper’s cancer” in the south-eastern 
United States due to the habit of placing snuff in the labial sulcus—the basis of 
the classic description of verrucous carcinoma by Ackermann,38 confirmed later 
by McCoy and Waldron.39 
As Axell 40, 41 points out, oral snuff almost always produces mucosal 
lesions, often affects salivary flow, causes gingival recession, and creates 
nicotine dependence and addiction. 
Role of Smoking: 
The most comprehensive source of evidence for the carcinogenicity of 
tobacco smoke remains the IARC publication of 1986.42  
This evidence is summarized by the U.S. Surgeon General’s Report of 
1989: upper aerodigestive sites have the highest Ars in males, of all the many 
sites influenced by smoking. A major difficulty in accurately quantifying 
smoking risks for aerodigestive tract cancer is its strong synergism with 
alcohol. 
Pipe smoking has long been associated with lip cancer, where the nature 
of the stem and its permeability and, maybe, temperature are cofactors. Some 
literature suggests that pipe and cigars are less risky for oral cancer than 
cigarettes 43 but a study from North Italy 27 shows higher risks associated with 
these practices for cancer of the mouth and esophagus than cigarettes. 
The relationship between smoking and the anatomical site of oral cancer 
is less clear-cut than with smokeless tobacco. Pooling of carcinogens in saliva 
leads to cancers in the “gutter” area—floor of the mouth and ventral and lateral 
tongue.  
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Mashberg and Meyers 44 reported in a U.S. population that 201 of 207 
asymptomatic, primarily erythroplastic carcinomas were in three locations: 
floor of mouth (101 carcinomas), ventral or lateral tongue (36 carcinomas), and 
soft palate (64 carcinomas).  
In the Amsterdam series 45 the floor of mouth and retromolar area were 
significantly more related to tobacco use than cancers or the tongue and cheek.  
However, in another series of 359 male cases among U.S. veterans, 
smoking was more strongly associated with soft palate cancers than anterior 
sites, and alcohol was associated with floor of mouth lesions.46  This is 
interesting because the long-recognized lesions of stomatitis nicotina (“smokers 
palate”) have a low malignant potential (except in reverse smokers). Stomatitis 
nicotina, in the West, is most commonly associated with pipe smoking and both 
hard and soft palate is relatively uncommon sites of oral cancer. 
 Bidis contain much higher levels of phenol, hydrogen cyanide, and 
benzo(a)pyrene than conventional cigarettes 61. Bidis and kreteks may in fact 
produce carcinogens other than those commonly found in tobacco. Flavoring 
agents added to bidis are not rigidly controlled, so the composition may be 
variable. Mutagenicity testing of flavoring agents is commonly done using 
aqueous or organic extracts. However, testing of the parent compound in this 
way may not identify potentially hazardous pyrolysis products formed during 
combustion of the flavoring agent. Combustion of virtually all organic matter 
produces polycyclic aromatic hydrocarbons, some of which may be metabolized 
to form carcinogenic epoxides.  
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Clove cigarettes contain the genotoxic phenyl propenes, safrole, eugenol 
and methyl eugenol which are established or suspected carcinogens in animal 
models 62. Furthermore, some spices that are not mutagenic based on an Ames 
assay of conventional extracts become mutagenic when treated first with nitrite 
63. Nitrite is abundant in tobacco, where it is the primary nitrosating agent 64. 
Adolescents and young adults may be particularly susceptible to 
exposures to oral carcinogens. Epidemiological studies 65 and mathematical 
carcinogenesis models 66 implicate young age at initiation of smoking as an 
independent risk factor for cancer. A recent study also showed that, at least in 
former smokers, young age was associated with higher levels of DNA adducts 
67.  
It is possible that the oral cavity may also show age-related 
susceptibility. Before puberty, children are not very susceptible to inflammatory 
conditions of the oral cavity such as gingivitis and periodontitis. However, 
puberty brings changes in oral mucosal cell proliferation rates, bacterial 
populations, and hormonal stimulation 68, 69. All of these can potentially 
contribute to altered sensitivity to carcinogens. 
The Mechanisms of Tobacco Carcinogenesis: 
More than 300 carcinogens have been identified in tobacco smoke or in 
its water-soluble components that would leach into saliva. 42 The major and 
most studied of these are the aromatic hydrocarbons - benz-pyrene and the 
tobacco specific nitrosamines (TSNs), nitroso-nor-nicotine (NNN), nitroso-
pyrrollidine (NPYR), nitroso-dimethylamine (NDMA), and 4-
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(methylnitrosamino)-1- (3-pyridyl) - 1-butanone (NNK). Benz-pyrene is a 
powerful carcinogen, with twenty to forty nanograms per cigarette.47 
Hoffman and Hecht 48 reviewed the role of N-nitrosamines. Mainstream 
cigarette smoke can contain NNN and NNK. These are generated primarily 
during pyrolysis, but also endogenously from some smokeless tobacco. They act 
locally, on keratinocyte stem cells, and are absorbed and act in many other 
tissues in the body. They produce DNA adducts, principally methyl Guanine, 
which interfere with DNA replication. There is damage to all replicating cells, 
including those of the immune response. Metabolism of these carcinogens 
usually involves oxygenation by p450 enzymes in cytochromes, and then 
conjugation, in which the enzyme glutathione S transferase (GST) is involved. 
Polymorphisms of the p450 and GST genes are currently under active study in 
the search for genetic markers of susceptibility to head and neck cancer, and 
indeed to tobacco-related cancers at many other body sites. 49 
Role of Alcohol: 
Pure ethanol has never been shown to be carcinogenic in vitro or in 
animal studies.42 It is presumed to act in concert with other, more direct, 
carcinogens in the beverage—so-called congeners—and with other 
environmental carcinogens, especially from tobacco.  
Nevertheless, an increased risk of upper aerodigestive tract cancer 
associated with alcohol drinking in non-smokers has been demonstrated. 50 The 
increase in oral cancer in the Western world has been related to rising alcohol 
use. In England and Wales, alcohol consumption per capita fell from the turn of 
the century to the 1930s, but has more than doubled since.  
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Using mortality from liver cirrhosis as a surrogate measure of damage 
to health from alcohol, Hindle 51 has plotted trends over this century and shown 
how they closely match the trends in oral cancer mortality. Taking deaths from 
lung cancer as a measure of tobacco damage, it is striking how the trends for 
oral cancer move, both down and up this century, in opposite directions: strong 
circumstantial evidence that alcohol rather than tobacco is the major factor in 
the observed trends in oral cancer mortality and, by inference, incidence. 
All forms of alcoholic drinks are dangerous if heavily consumed, the most 
dangerous reflecting the predominant habit in the population under study. Thus 
there is evidence for the role of beer52, 53 wine 54, 27 and spirits 55.  
It is notable that the 95 percent confidence intervals for the odds ratio for 
all beverages do not cross unity until the total consumption is really quite high - 
above fifty-five drinks per week. This is consistent with other data.56 
When the tobacco effect is adjusted for, heavy alcohol consumption itself 
produces considerable risks, with ORs or RRs of 17, 23, 33, and 70 appearing for 
oral cancer in the different studies. For these high rates of alcohol use/abuse, the 
risks are greater than for tobacco, adjusted for alcohol. Self-reported alcohol 
consumption tends to be underestimated, implying that alcohol may be even 
more important. 
Alcohol is also high in calories, which suppresses appetite. Those with a 
serious drinking problem become socially fractured, and many choose to spend 
available cash on drink rather than food. All of this contributes to inadequate 
diet. Metabolism is further damaged by liver disease. As a result, nutritional 
deficiencies are common.57 
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Effects of alcohol on oral mucosa: 
There was a highly significant decrease in the mean cytoplasmic area 
and a significant reduction in the mean nuclear area of cells from the alcohol 
group which did not vary with age. This may be due to the direct effect of 
alcohol, which may have a dehydration effect. 
Mascres et al 148 observed epithelial atrophy in esophageal mucosa of 
rats after chronic alcohol ingestion, which they associated with a reduction in 
basal cell size. 
Maier et al 149 observed epithelial atrophy on oral mucosa of rats after 
chronic alcohol consumption. However, they found an increase in basal cell size 
which they attributed to hyper-regeneration in response to ethanol cytotoxicity. 
They attributed the epithelial atrophy to a reduction in thickness of the 
maturation cell layer. However, they did not measure cell size in this layer, so it 
is unclear if this was due to a reduction in the number of cell layers or to a 
reduction in the size of the cells in the maturation layer. 
Valentine et al 150 noted epithelial atrophy in human lingual epithelium 
due to alcohol and tobacco consumption. He found an increase in basal cell size 
associated with alcohol and a decrease in size of the more superficial cells. 
Anderson 151 looked at oral smears from 3445 dental patients and 276 
alcoholic patients over a three year period. He found a statistically significant 
increase in the number of dyskeratotic cells within the alcohol group compared 
with that of controls. 
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Hillman and Kissin 152 looked at oral cytology patterns in relation to 
smoking within 790 alcoholic subjects. They found a significant increase in 
nuclear and cell size in smokers compared with non-smokers. 
Ogden et al 153 assessed the effects of tobacco smoking of more than 
twenty cigarettes per day, in non-anemic, age and gender matched controls and 
found out that there was only a slight increase in nuclear level (5%). 
Mechanism of Alcohol carcinogenesis: 
 Most alcohol is metabolized by alcohol dehydrogenase into acetaldehyde, 
a highly toxic substance suspected to cause the tissue damage attributed to 
alcohol ingestion. However acetaldehyde is rapidly metabolized to a non-toxic 
form of acetate by aldehyde dehydrogenase. Thus individual variation in the 
oxidation of ethanol to acetaldehyde and in particular, the length of time 
required to catalyze the conversion of acetaldehyde to acetic acid by 
acetaldehyde dehydrogenase (ALDH).  
 Alcohol dehydrogenase and Aldehyde dehydrogenase activity have been 
demonstrated in the oral cavity 154. Individual variations in such enzyme levels 
may help explain different oral cellular responses between individuals within 
the alcohol group. 
 There is strong epidemiological evidence that combined use of alcohol 
and tobacco has a synergistic effect in the etiology of oral cancer. The 
concentration of tobacco-specific nitrosamines is very high in saliva and that 
extended contact with oral mucosa occurs with usage of smokeless tobacco. 
Ethanol has been shown to be a penetration enhancer for epithelial tissue 155 and 
there could be increased penetration of the carcinogens into the oral epithelium.  
 28
 Ethanol is used as an effective permeability enhancer for drug delivery 
across skin, with a maximum effect at concentrations between 20 – 40%, 
depending on the nature of the penetrating compound 156. This effect may reflect 
enhancement of a pathway through a liquid crystal lipid phase of the 
intercellular lipid barrier of the stratum corneum 157.  
A similar mechanism may explain permeability enhancement in non-
keratinized oral mucosa where the epithelial barrier is also represented by 
intercellular lipids, although probably with more extensive liquid crystalline 
membrane domains and less extensive gel phase domains than in epidermis 158. 
The absence of significant permeability effect with 50% ethanol could be due to 
the fixative effect of higher concentrations of ethanol in tissue, perhaps 
involving dehydration of the more aqueous pathways penetrating the liquid 
domains of the intercellular barrier 156. Studies reveal that 25-30% ethanol 
significantly increased the penetration of NNN across the floor of mouth 
mucosa. Since the floor of the mouth is the most permeable area of the oral 
cavity, and since this region has been suggested to have the highest risk for 
developing oral cancer, the permeabilizing effect of alcohol could explain the 
synergistic role of alcohol with tobacco 159. The risk of cancer with smoking and 
drinking is tabulated below,  
Head and Neck Cancer in Non-Users of Tobacco and/or Alcohol: 
A minority of patients develop a cancer in the apparent absence of one or 
both of these risk factors.  
Rich and Radden 58, the Amsterdam data 45, Hodge et al 59 , Bross and 
Coombs15, Wiseman et al2, Koch WM, Lango M, Sewell D, et al16, Blot et al5, 
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Llewellyn et al 19, Constantinides et al.20, Agudelo D et al 21, Lemon FR, Walden 
RT, Woods RW.22, Phillips RL23, de Boer MF, Sanderson RJ, Damhuis RA, et al 
24, Hodge et al 17, Panis et al 18, Kotwall et al 25, Slaughter et al 26 have reported 
the incidence of oral cancer in patients who are non-users of tobacco and 
alcohol.  
None of these studies on the rare cases that occur in non-users of tobacco 
and/or alcohol dilutes the evidence that these are far and away the major risk 
factors. Viral infections and nutritional inadequacies are the main hypothetical 
factors in this group of patients. 
Verrucous carcinoma: 
 The first case report was published in 1941 by Friedell and Rosenthal 166 
who described it as papillary verrucoid carcinoma. Then in 1948, Lauren V. 
Ackerman 160, 167 reported a series of 31 similar oral cases and described a 
neoplasm of the oral mucous membrane, which he thought represented a unique 
type of squamous cell carcinoma and coined the term verrucous carcinoma with 
the characteristic clinical and histological findings. 
 Verrucous carcinomata are rare tumors of the oral cavity, representing 
anywhere from 1 to 10% of all oral squamous malignancies 163. The most 
common sites of involvement in the mouth are the buccal mucosa and gingiva, 
the alveolar ridge, the palate, and the tongue. Compared with conventional 
squamous cell tumors of the head and neck, they tend to present at an advanced 
age, with a higher proportion of female patients 164. 
Although these tumors are classified as carcinomata, they are extremely 
well-differentiated rare variants of squamous carcinoma with little or no 
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metastatic potential. However, they cause significant morbidity because of their 
local invasiveness and their pattern of stubborn recurrence with the currently 
acceptable modalities of radiation and surgery 165. 
 The formal definition 167 refers to a warty and densely keratinized 
surface. The lesion is contained within a sharply circumscribed deep margin. 
Close inspection reveals bulbous well-oriented rete ridges with well-keratinized 
squamous epithelium with no anaplasia. One of the most distinguishing features 
is a pushing rather than infiltrating type of advancing margin. There is 
associated inflammation in the adjacent stroma. 
Prioleau et al 161 performed a study on verrucous carcinomas of the 
rectum, plantar surface of the foot, and oral cavity were studied by means of 
light and electron microscopy, and autoradiographic and immunofluorescent 
techniques. Histologic examination showed that each tumor was composed 
mainly of mature squamous epithelium, and each had foci of slight cellular 
atypia. The cells in S-phase consistently were situated near the basal layer. 
Immunofluorescent examination with antibasement membrane antibody 
showed areas of marked focal thickening and other areas where basement 
membrane was absent. Ultrastructural examination showed reduplicated as 
well as normal basal lamina. Numerous interdigitating microvilli and well 
developed desmosomes characterized the cells above the basal layer. A 
proliferative basal zone underlying a thick layer of well differentiated non-
proliferating keratinocytes and reduplicated basal lamina were seen in all 
tumors, regardless of location. These consistent findings constitute evidence that 
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verrucous carcinoma is a morphologic and cytokinetic entity that may occur in 
multiple anatomic sites. 
 Jiang et al 162 studied the immunohistochemical alteration of basement 
membrane (BM) type IV collagen and laminin in oral verrucous carcinoma and 
its BM ultrastructural variations in 16 cases of oral verrucous carcinoma 
(OVC), 10 cases of oral squamous cell carcinoma (OSCC) and 9 cases of oral 
mild to severe epithelial dysplasia (OMSD) by using a immunohistochemical S-P 
method, and the results were analyzed by quantitative method. 3 cases of OVC 
were observed by TEM. The BM in OVC was thicker than in OSCC and OMSD. 
TEM found the basal lamina in some areas showed a marked reduplication. The 
BM in OVC was generally intact (13/16), whereas in OSCC it was mostly 
discontinuous (9/10), especially around the neoplasm front or the small cord 
consisted of a few cells, and mostly continuous in OMSD (6/9). There was a 
stromal inflammatory infiltration around tumor nests for all the oral lesions, 
but it was much heavier in OVC than that in OSCC and OMSD (P < 0.05). There 
was a positive correlation between intraepithelial lymphocytic infiltration and 
the BM continuity for OVC (P < 0.01). He concluded that the more continuous 
BM and the heavier inflammatory infiltration in the connective tissue of OVC 
may be related to its biological behavior. 
Leukoplakia: 
The term leukoplakia was first used by Schwimmer in 1877 to describe a 
white lesion of the tongue, which probably represented a syphilitic glossitis. 170 
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In 1978, World Health Organization group defined oral leukoplakia as, 
“A white patch or plaque that cannot be characterized, clinically or 
histopathologically, as any other disease”146. 
At the international seminar held in 1983, the outcome of which was 
published in 1984 80, it was decided to avoid the use of the term leukoplakia 
where there was a known etiological factor, except in those cases where tobacco 
was believed to be the cause.  
Thus the previous definition was revised to “Leukoplakia is a whitish 
patch or plaque that cannot be characterized clinically or pathologically as any 
other disease and it is not associated with any physical or chemical causative 
agent except the use of tobacco”. 
The etiological description identified two categories of leukoplakia: those 
of unknown etiology (idiopathic) and those associated with, or thought to result 
from, the use of tobacco (tobacco-associated). 
The clinical variants to be recognized are, 
1) Homogeneous leukoplakia: 
2) Non-homogeneous leukoplakia: 
Proposal for a LCP Classification and Staging system for Oral leukoplakia: 
L prov (isional): A provisional diagnosis of oral leukoplakia is made when a 
lesion at clinical examination cannot be clearly diagnosed as any other disease 
of the oral mucosa  with a white appearance. 
L def (initive): A definitive diagnosis of oral leukoplakia is made as a result of 
the identification, and if possible, elimination, of suspected etiologic factors and, 
in the case of persistent lesions, histopathological examination. 
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L prov: 
1st symbol (L) represents the size: 
 1 = < 2cm 2 = > 2 to 4 cm 3 = > 4cm x = Not specified 
2nd symbol (C) represents the clinical aspect, 
 1 = homogeneous 2 = non-homogeneous x = Not specified 
L def: 
3rd symbol (P) represents the pathological features: 
 1 = no dysplasia 2 = mild dysplasia 3 = moderate dysplasia 
 4 = severe dysplasia x = not specified 
Stage grouping: (only for leukoplakias that have been examined 
histologically) 
Stage 1: any L C1 P1 P2, Stage 2: any L C2 P1 P2, Stage 3:  any L any C P3 P4 
Prevalence of Oral Leukoplakia: 
According to well-documented epidemiologic data from different 
countries over the last thirty years, the prevalence of oral leukoplakia varies 
between 1.1 and 11.7 percent, with a mean value of 2.9 percent. 73 - 79 
This range reflects assessments made on the basis of different definitions 
of oral leukoplakia, 80 -82 which can result in different prevalence rates.  
Smoking and the Prevalence of Oral Leukoplakia: 
Early descriptive studies (performed mainly in India and Denmark) have 
shown that the frequency of oral leukoplakia among smokers is so high that, in 
the absence of controls, the habit could be considered as causative.  
Cross-sectional studies indicate the risk for oral leukoplakia between 
smokers and nonsmokers. The smoking habits in India show a varying 
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association with locally prevailing tobacco habits, i.e., chewing, smoking, and 
mixed habits (chewing betel quid and bidi smoking). All habits were associated 
with the onset of oral leukoplakia, and the prevalence was considerably higher 
among the tobacco-using groups than the non-users.  
Renstrup 83, Pindborg, Roed-Petersen, and Renstrup 84,Roed-Petersen 
and Pindborg 85, Mehta et al. 86, Dombi et al.,87, Bruszt88  have reported the 
association of smoking and incidence of leukoplakia. 
The studies that report on the distribution of leukoplakia cases according 
to smoking habits are Banoczy and Rigo 89, a case-control study from Kenya 90, 
Downer’s study 91 and Winn 79. 
Evidence from Tobacco Intervention Studies: 
A decrease in the prevalence of oral leukoplakia after smoking cessation 
has been observed in many studies, confirming an etiological role.  
Banoczy 92, Roed- Petersenís study 93, Gupta et al 94 have reported 
resolution of leukoplakia after cessation of smoking habits. 
In a recent study of 3,051 male U.S. military trainees, among the 302 
individuals using smokeless tobacco, 39.3 percent had leukoplakia compared to 
1.5 percent among non-users. After six weeks of tobacco cessation, 97.5 percent 
of leukoplakic lesions showed complete resolution clinically. 95 
Role of Smoking in Malignant Transformation of Oral Leukoplakia: 
The studies cited above mostly provide evidence of the role of smoking in 
the development of oral leukoplakia. However, there is also strong evidence of a 
relationship between tobacco use and the development of oral cancer, although 
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it is not clear whether smoking promotes the development of cancer from oral 
leukoplakia.  
Earlier studies have showed an increased risk of malignant 
transformation of oral leukoplakia among non-smokers. Einhorn and Wersall 96 
cite an eight-fold risk in Sweden, and Roed-Petersen 93 a fivefold risk in 
Denmark.  
Banoczy’s 97, 98, Silverman, Rozen 99, Silverman, Gorsky, and Lozada 100 
have reported varied rates of transformation of leukoplakia into carcinoma.  
However, as relatively few leukoplakias transform into cancer, it is 
difficult to determine the role of tobacco in this process. 
Histopathology of Leukoplakia: 
 Loning T and Burkhardt A(1979) 171 assessed the sub-epithelial and 
peritumoral inflammatory infiltrates of 202 oral premalignant and malignant 
lesions -- 108 leukoplakias and 94 squamous cell carcinomata with different 
grades of dysplasia using an immuno-enzymatic method. The incidence of 
immunoglobulin labeled plasma cells (IgA and IgG) was twice as high in those 
cases of leukoplakia where dysplasia was present. The number of plasma cells, 
especially IgA- and IgG-containing plasma cells, decreased significantly with 
progressive tumor dedifferentiation. In the epithelium, IgA and IgG were 
localized throughout all epithelial layers in leukoplakias with dysplasia. This 
finding indicates a leakage of locally synthesized immunoglobulins through an 
altered oral mucosa. This investigation revealed alterations in the local immune 
homoeostasis of the oral mucosa in premalignant and malignant lesions which 
varies with the grade of dysplasia, tumor differentiation and therapy. 
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Rodriguez-Perez I and Banoczy J (1982) 172 analyzed the histological 
sections from 100 leukoplakia patients in order to define the characteristics of 
epithelial and connective tissue alterations and the possible correlation of these 
changes. Parakeratosis was found in 39% of the cases, orthokeratosis in 24% 
and both types of keratinization in 34% of the cases. The most characteristic 
alteration of the thickness of the epithelium was hyperplasia in 81% of the cases. 
Epithelial dysplasia was present in 27% of the samples. A chronic inflammatory 
infiltration was generally present in the subepithelial region and in some cases 
within the epithelium. An increase in the number of these cells related to 
hyperplasia, parakeratosis and dysplasia has also been found. These results 
may be interpreted as a possible relation between epithelial and connective 
tissue changes in leukoplakia lesions. 
Banoczy J, Lapis K, Albrecht M (1980) 173 studied the biopsy specimens of 
buccal mucosa from six oral leukoplakia patients and one specimen of normal 
buccal mucosa by scanning electron microscopy. The results showed a 
difference between the surfaces of normal and leukoplakic epithelial cells. The 
appearance varied with the clinical type of leukoplakia: in leukoplakia 
verrucosa, epithelial cells appeared keratinized; in leukoplakia erosiva, 
epithelial cells were dissociated. Histologically, dysplastic erosive leukoplakia 
was characterized by an atypical arrangement of superficial cytoplasmic 
projections of epithelial cells. 
Bondad-Palmario GG (1995) 174 analyzed the phenotype and distribution 
of immunocompetent cells in 100 cases of oral leukoplakia with different levels 
of dysplasia. Cells were identified in two compartments of the oral mucosa, the 
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epithelium and subepithelial connective tissue. In the main lymphoid population 
of each groups, the T lymphocytes predominated over the B lymphocytes. The 
lymphoid cells were present either as diffuse aggregates or organized in 
follicular patterns with or without germinal center-like structures. When 
present, B lymphocytes were seen to constitute the above mentioned structures. 
T lymphocytes made up the paracortical areas. A decrease in CD4/CD8 ratio 
was observed in cases with severe dysplasia. Specimens classified as mild to 
severe dysplasia presented a significant increase in the number of CD1a (+) 
dendritic Langerhans cells when compared with those of epithelial hyperplasia. 
A significant increase in macrophage count was also obtained in the sub-
epithelial connective tissue of all dysplastic cases. A significant increase of CD57 
(+) natural killer/killer cells in the subepithelial connective tissue and HLA-DR 
expression by the keratinocytes was observed in cases with severe dysplasia. 
Correlation and analysis of the results revealed an immuno-cellular reaction 
that varied according to the degree of dysplasia in oral leukoplakia. 
Immunologic events, i.e. decreased CD4/CD8 ratio, increased density of natural 
killer/killer cells and HLA-DR expression by keratinocytes, occurring 
simultaneously in severe dysplasia are speculated to be indicative of early 
malignant transformation. 
Effect of Smoking on Clinically Healthy Oral Mucosa: 
Several investigators have studied the question of whether the structure 
of the clinically healthy oral mucosa shows any alterations in smokers.  
Banoczy 101 reported on the results of cytological examination of oral 
smears in 100 healthy, male and female smokers and non-smokers. Evaluation 
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of the keratinization pattern revealed a significant increase in keratinized cells 
in the epithelium of the tongue and hard palate of both male and female 
smokers, when compared with non-smokers.  
Meyer, Rubinstein, and Medak 102 took smears of ten clinically normal 
regions from ninety-nine subjects and found that smoking affected 
keratinocytes differently in different regions, depending on the extent of direct 
exposure to smoke. The initial changes were more marked in non-keratinized 
than in keratinized regions and, interestingly, were in the direction of a less 
differentiated cell type. The results of both studies point to cellular alterations 
preceding the clinical changes. 
Oral Sub mucous fibrosis: 
It is approximately half a century since Schwartz described this condition 
in the tobacco-chewing women of Indian origin in Kenya. Since then this 
condition evoked an intense enthusiasm among many researches in India and 
through out the world.  
Various authors had investigated the condition thoroughly and proposed 
several factors that play a role in the etiopathogenesis of this condition. Current 
evidence suggests that arecoline in the areca nut is the key factor in initiating 
the disease process. 
This condition is aptly described by Pindborg and Sirsat as “an insidious 
chronic disease affecting any part of the oral cavity and some times the pharynx. 
Although occasionally preceded by and/or associated with vesicle formation, it is 
always associated with a juxta-epithelial inflammatory reaction followed by a 
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fibroelastic change of the lamina propria, with epithelial atrophy leading to 
stiffness of the oral mucosa and causing trismus and inability to eat”. 
The habit of betel quid chewing is widespread throughout India and 
South East Asia. This condition is also reported in Asian immigrants living in 
other parts of the world.  
Various researchers have conducted studies in different parts of the 
country to check out the incidence of betel quid chewing habit in general 
population. This habit is widely prevalent in teenagers and young adults.  
Oral submucous fibrosis predominantly involves the oral cavity. The 
buccal mucosa, retromolar area, and the soft palate are the predominantly 
affected sites. The mucosa in the involved areas gradually becomes pale 
followed by progressive stiffness of subepithelial tissues.  
In addition to the involvement of oral mucosa, this condition also 
involves the pharynx and esophagus in persons who chew and swallow the 
products of betel quid.  
Recently, an increased incidence of malignancy is noted in oral 
submucous fibrosis patients, particularly in people who use commercially 
available products. The malignant transformation of betel quid users in India is 
around 8%, which is quite high 115, 145. 
The most ironical aspect of this condition is lack of appropriate treatment 
modalities. Unlike tobacco pouch keratosis, oral submucous fibrosis does not 
regress with the habit cessation, although mild cases may be treated with 
intralesional corticosteroids to reduce the symptoms.  
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Surgical splinting and excision of the fibrous bands have also been tried 
to improve the mouth opening in later stages of the disease. A recent study 
showed that intralesional injections of interferon gamma improved maximum 
mouth opening, reduced mucosal burning and increased suppleness of the 
buccal mucosa. 
Historical Review: 
This condition was first described in ancient Indian Medical Manuscripts 
by Sushruta at the time of around 400 B.C. describing it as “VEDARI”, where he 
gives description of patients suffering from narrowing of mouth, burning 
sensation and pain.   
Schwartz (1952) reported a condition consisting of limitation of mouth 
opening amongst south Indian women in Kenya, which he named “atrophia 
idiopathica (tropica) mucosa oris”. 
Joshi (1953) an ENT surgeon observed this condition and termed as 
“submucous fibrosis of palate and pillars of fauces”.    
 Of all the terminologies in the literature, the term “Oral Sub-mucous 
Fibrosis” is currently widely used. 
Etiology: 
 Although various etiological agents are proposed, the exact etiology of 
oral submucous fibrosis has not yet been identified. Current evidence suggests 
that arecoline in betel nut plays a major role in initiating the disease process.  
Various etiological agents are summarized by Abrol.  
Su (1954), Rao (1962), Sirsat & Khanolkar (1962), Gupta D.S. et al (1980), 
Pindborg & Sirsat (1964), Abrol & Krishnamoorthy (1970), Abrol & Raveendran 
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(1972), Ramanathan K (1981), Canif. J.P & Harvey.W (1986)117, Sinor P.N. et al 
(1990) 118, Binnie & Cawson (1972) 119, Caniff & Pillai, Gollinick et al, Khanna. J. 
N & Andrade. N. N (1995) 120 have reported the various etiological factors for 
sub mucous fibrosis.. 
Malignant potential: 
Paymaster first reported the development of slow growing oral 
carcinoma in 1/3rd of cases seen at Tata Memorial Hospital, Bombay (J.J. 
Pindborg et al, 1966). 
Pindborg et al (1975) 121 , Caniff. J.P et al (1986) 122, Pindborg & Murthy, 
Shiau & Kwan, Glenn Muraw et al (1987), Maher. R. et al (1996) 123 have 
reported varied incidences of dysplasia and malignant transformation in sub 
mucous fibrosis. 
Clinical features: 
Age incidences given by various authors, based on their studies varied 
between 10 to 60 years. 
Sex incidence also varies amongst various studies, most authors 
suggested a male preponderance, but Maher (1996) 123 have given an increased 
female predilection. 
The sites commonly involved according to Wahi et al (1966) 124, are 
palate (51.3%), buccal Mucosa (44.2%), tongue (2.7%), lip and gingiva (0.9%). 
Wahi et al (1966)124 classified submucous fibrosis into three clinical 
groups namely, Group I, Group II and Group III.  
Pindborg et al (1966) 125,  McGurk et al Gupta et al (1980) 115, Caniff & El-
Labban (1985) 126, Vaish et al (1981) 127, Glenn Morawetz et al (1987), Caniff. J.P 
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et al (1986)122, Moos and Madan 1968) 130, Wahi et al 1966) 124, Pindborg et al 
1980) 131 have reported variations in clinical features of sub mucous fibrosis. 
Borle. R.M & Borle. S.M (1991) 129 have classified oral submucous fibrosis 
clinically into two phases, an eruptive phase and an fibrosis induction phase. 
Histo-pathological features: 
Joshi (1953) mentions frequent presence of intra-epithelial vesicles in 
early stages of disease. Other changes include parakeratosis, signet cell 
degeneration, liquefaction degeneration of basal layers. 
Pindborg J.J,  Mehta F.S, Daftary D.K 121 reported that out of 53 cases of 
biopsy specimens observed, 71.7% of biopsies showed atrophic epithelium, 
normal thickness in 26.4% and hyperplastic epithelium in 1.9%. In 26% of cases, 
buccal mucosa showed hyper-orthokeratosis, 22% showed hyper-parakeratosis 
and 52% showed non-keratinized surface.  22.6% cases showed epithelial atypia 
with intercellular edema. 19.2% of biopsies showed signet cells in basal layer.  
There was reduction of melanin pigment in basal cell layer and 3 biopsies 
revealed presence of colloid bodies in epithelium and marked lymphocyte 
infiltration in lamina propria. 
McGurk et al (1984) 132 observed subepithelial chronic inflammatory 
reaction and accumulation of dense collagen at dermo-epidermal junction with 
extension of the fibrosis down into the submucous and voluntary muscle. 
El-Laban NG and Caniff J.P. (1985) 133 studied ultra structural findings of 
muscles degeneration in OSMF.  He demonstrated severe necrosis in high 
proportion of muscle fibers. 
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Caniff J.P, Harvey, Harris (1986) 122 examined 30 cases and showed 
atrophic epithelium in 26%, 33% had non-keratinized epithelia, 27% had mild 
and 7% showed moderate atypia.  All 30 cases (100%) showed collagen 
accumulation beneath basement membrane and chronic inflammatory cell 
infiltrate consisting of lymphocytes, plasma cells monocytes, and macrophages 
within lamina propria. 
De Waal et al (1997) 134 studied the fibroblast content in SMF. They 
observed an increase in F-3 cells which produced type I and type III collagen in 
excess amounts in oral submucous fibrosis. 
Immunological, Biochemical and Hematologic Features: 
Pindborg et al, Dinesh. S. Gupta et al (1980) 135 , Rajendran R et al (1986) 
136, Canif J.P, Harvey, Harris (1986) 122, Glenn Morawetz et al (1987) 128, 
Chaturvedi V. N & Marathe. N. G. (1988) 138, Anuradha. C. D and Shyamala 
Devi C. S (1998) 139 have reported the immunological and hematological 
variations in sub mucous fibrosis. 
Scutt A et al (1987) 137 observed that treatment of reconstituted collagen 
fibrils and pieces of rat dermis with the crude extract, purified tannins or (+)-
catechin from betel nut (Areca catechu) increases their resistance to both human 
and bacterial collagenases in a concentration-dependent manner. These 
tanning agents may stabilize collagen in vivo following damage to the oral 
epithelium, and promote the sub-epithelial fibrosis which occurs in betel nut 
chewers. 
Haque. M.F et al (1997) 140, Kaur J et al (1999) 141, Trivedy C et al (1999) 142, 
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Chiang CP et al (2000) 143, Mythily Srinivasan et al (2001) 144 have evaluated the 
various histochemical and molecular changes in sub mucous fibrosis. 
 Mollenhauer and Bayreuther 208 described three distinct fibroblast cell 
forms in rat connective tissue that can be identified on the basis of their 
morphology. They can also be distinguished from one another by the amount 
and type of collagen synthesized. 
1. The F1 fibroblast is spindle shaped, highly proliferative and secretes low 
levels of type I and III collagen. 
2. The F2 fibroblast is more epitheloid, less proliferative and synthesizes 
relatively more collagen. 
3. The F3 fibroblast is a large stellate cell and the least proliferative, 
produces four to eight times more types I and III collagen than F1. 
According to these workers, F2 cells sequentially arise from F1 cells and F3 
cells sequentially arise from F2 cells. 
Role of sub-epithelial connective tissue and inflammatory cells in 
differentiation of epithelium: 
Squier CA and Kammeyer GA (1983) 175 performed a study in which the 
specimens of buccal mucosa and ear skin were introduced into the uteri of 
isologous rats and the animals maintained under estrogen stimulation for ten 
weeks, whereupon the uteri were removed and processed for light- and 
electron-microscopic examination. The majority of implants were successful 
with the epithelium having migrated to replace the adjacent uterine epithelium. 
Epidermis and oral epithelium growing on its own connective tissue in the 
uterus showed a normal pattern of histodifferentiation, including the formation 
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of a thickened keratinized surface and appendages such as hair and sebaceous 
glands. Ultrastructurally, maturation was similar to that of normal tissue. 
Epidermis growing on uterine connective tissue did not form appendages but 
the ultrastructural pattern of cytodifferentiation was similar to control tissue. 
Buccal epithelium on the uterine stroma was markedly altered in its pattern of 
maturation, the epithelium appearing thinner than usual and showing a 
pattern of maturation resembling that of non-keratinization. These results 
suggest that normal histodifferentiation in epidermis and oral epithelium 
requires the presence of the appropriate connective tissue; in its absence 
epidermis has an intrinsic capacity for more or less normal cytodifferentiation 
but this is lacking in the buccal epithelium. 
Mackenzie IC, Hill MW (1984) 176 assessed the epithelial-mesenchymal 
interactions and their influence on the maintenance of epithelial structure in the 
adult. To examine this problem, separated epithelial and connective tissue 
components of skin and mucosae from various regions of adult mice were 
homo-or heterotypically recombined and transplanted to histo-compatible 
hosts. The patterns of tissue architecture and keratinization of the resultant 
epithelia were examined for changes indicative of mesenchymal influences on 
the epithelial phenotype. Each type of epithelium, in some recombinations, fully 
conserved its normal pattern of phenotypic expression indicating that 
subepithelial connective tissue from all regions is permissive and that 
regionally-specific connective tissue influences are not necessary for 
conservation of epithelial specificity. In other recombinations, however, the 
epithelium acquired features of tissue architecture or keratinization typical of 
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the epithelium normally associated with the connective tissue component, 
indicating directive influences from the connective tissue. The patterns of 
epithelial response observed suggest that there may be separate connective 
tissue influences on epithelial architecture and cyto-differentiation and that 
there is a regionally-related variation in the competence of epithelia to respond 
to these influences. 
Hill MW, Mackenzie IC (1989) 177 assessed the role of subepithelial 
connective tissue in modulating the pattern of histodifferentiation and epithelial 
proliferative activity of stratified epithelia from adult animals. Epithelial and 
connective tissues of murine skin and oral mucosa, differing in their 
morphology and proliferative activity, were separated and heterotypically 
recombined prior to grafting to histocompatible hosts. After 3 or 8 weeks in situ, 
mitotic activity was determined following the administration of vinblastine 
sulfate. Although the mitotic activity in each of the epithelia could be modulated 
by some connective tissues, there was no distinct pattern of behavior. In 
combination with connective tissues from tongue or palate, the ear epidermis 
acquired a significantly increased mitotic activity. In contrast, when oral 
epithelia with high mitotic activity were recombined with dermal connective 
tissue, there was usually a significant reduction in proliferative activity. As 
there was no apparent association between mitotic activity and the induced 
changes in either organization or histodifferentiation, it is suggested that 
subepithelial connective tissue is capable of directly influencing the mitotic 
activity in the overlying epithelium. 
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The stratified squamous epithelia differ regionally in their patterns of 
morphogenesis and differentiation. Although some reports suggested that the 
adult epithelial phenotype is an intrinsic property of the epithelium, there is 
increasing evidence that subepithelial connective tissue can modify the 
phenotypic expression of the epithelium. Okazaki et al 178 elucidated whether the 
differentiation of cutaneous and oral epithelia is influenced by underlying 
mesenchymal tissues. Three normal skin samples and three normal buccal 
mucosa samples were used for the experiments. Skin equivalents were 
constructed in four ways, depending on the combinations of keratinocytes 
(cutaneous or mucosal keratinocytes) and fibroblasts (dermal or mucosal 
fibroblasts), and the effects of subepithelial fibroblasts on the differentiation of 
oral and cutaneous keratinocytes were studied with histological examinations 
and immunohistochemical analyses with anti-cytokeratin (keratins 10 and 13) 
antibodies. For each experiment, three paired skin equivalents were constructed 
by using single parent keratinocyte and fibroblast sources for each group; 
consequently, nine (3 x 3) organotypic cultures per group were constructed and 
studied. The oral and cutaneous epithelial cells maintained their intrinsic 
keratin expression. The keratin expression patterns in oral and cutaneous 
epithelia of skin equivalents were generally similar to their original patterns 
but were partly modified exogenously by the topologically different fibroblasts. 
The mucosal keratinocytes were more differentiated and expressed keratin 10 
when cocultured with dermal fibroblasts, and the expression patterns of keratin 
13 in cutaneous keratinocytes co-cultured with mucosal fibroblasts were 
different from those in keratinocytes co-cultured with cutaneous fibroblasts. The 
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results suggested that the epithelial phenotype and keratin expression could be 
extrinsically modified by mesenchymal fibroblasts. 
In an effort to come to a better understanding of human oral mucosal 
carcinogenesis, Rich AM and Reade PC (2001) 179 used an animal model in 
which the carcinogen - 4-nitroquinoline-1-oxide was applied to rat palatal 
mucosa for varying periods of time. Histological and histometric analyses 
showed that there were quantifiable differences in the palatal epithelium to 
which carcinogen had been applied in comparison with control tissue. Tissue 
recombination experiments, using various combinations of the palatal mucosa 
and analyzed after recovery from transplantation to hypothymic BALB/c mice, 
showed that control epithelium recombined with connective tissue from 
carcinogen-treated mucosa was altered, indicating that the underlying 
connective tissue modified histomorphological aspects of the epithelium in the 
later stages of carcinogenesis 
Gannot et al (2002) 180 assessed the mononuclear infiltration in 
epithelium derived lesions of various pathological manifestations by histology 
and immunohistochemistry. The infiltrate under the transformed epithelium of 
oral lesions, was examined for differences in the composition of immune 
mononuclear cells as the epithelium moves from hyperkeratosis through 
various degrees of dysplasia to squamous cell carcinoma. The study was 
performed on 53 human tongue tissues diagnosed as hyperkeratosis (11 cases), 
mild dysplasia (nine cases), moderate and severe dysplasia (14 cases) and 
squamous cell carcinoma (19 cases). Immunohistochemical analysis of various 
surface markers of the tumour infiltrating immune cells was performed and 
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correlated with the transformation level as defined by morphology and the 
expression of p53 in the epithelium. The results revealed that, in the tongue 
lesions, the changes in the epithelium from normal appearance to transformed 
were accompanied by a corresponding increase in the infiltration of CD4, CD8, 
CD14, CD19+20, and HLA/DR positive cells. The most significant change was 
an increase in B lymphocytes in tongue lesions, that was in accordance with the 
transformation level (P<0.001).  
Autofluorescence and History of Fluorescent Probes: 
Emission of light by matter (luminescence) has always been known to 
man. Lightning in the sky, light emission by bacteria in the sea or by decaying 
organic matter are common natural phenomena.  
Scientific investigation of the luminescence phenomena began, when the 
Bolognian stone was discovered in 1603. 
In 1603 - Vincenzo Casciarolo, a Bolognian shoemaker and an alchemist, 
prepared an artificial phosphor by accident. It was known as the Bolognian 
stone (or Bolognian phosphor) which glows after exposure to light.  
In 1630 - Galileo Galilei (1564-1642), an Italian scientist, had the view on 
the Bolognian stone: "It must be explained how it happens that the light is 
conceived into the stone, and is given back after some time, as in childbirth."  
In 1646- Athanasius Kircher, a German Jesuit priest recorded an 
interesting observation of the wood extract of Lignum nephriticum. An aqueous 
infusion of this wood exhibited blue color by reflected light and yellow color by 
transmitted light. The blue light is actually a type of light emission 
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(fluorescence) and therefore Kircher is often regarded as the “Discoverer of 
fluorescence”.  
In 1838- David Brewster, a Scottish preacher used the term "internal 
dispersion" to describe fluorescence phenomena.  
In 1852- George Stokes, professor of mathematics and physics at 
Cambridge, interpreted the light-emitting phenomenon and formulated the law 
(the Stokes Law or the Stokes Shift) that the fluorescent light is of longer 
wavelength than the exciting light.  
In 1853- Stokes coined the term "fluorescence" from the term "internal 
dispersion."  
In 1856- William Perkin, an English chemist synthesized a coal-tar dye, 
aniline purple (the first synthetic dye). His breakthrough attracted the attention 
of numerous synthetic chemists and a variety of dyes were synthesized. Perkin 
was acknowledged as the Founder of the synthetic dye industry.  
In 1864- Stokes lectured "On the application of the optical properties to 
detection and discrimination of organic substances" before the Chemical Society 
and the Royal Institution.  
In 1871- Adolph Von Baeyer, a German chemist synthesized a fluorescent 
dye, fluoresceine.  
In 1880- A German firm known as Dr. G. Greublers Chemisches 
Laboratorium started to test and package the most desirable dyes for biologists 
and medical researchers.  
In 1882- Paul Erlich, a German bacteriologist employed the fluorescent 
dye uranin (sodium salt fluorescein) to track the pathway of secretion of 
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aqueous humor in the eye. This is the first case of the use of in vivo 
fluorochroming in animal physiology.  
In 1884- The Gram stain, a method for staining bacteria, which contains 
gentian violet as an essential component was developed by Hans Gram, a 
Danish physician.  
In 1887- Karl Noack, a professor in Geissen published a book listing 
about 660 fluorescent compounds, arranged according to the color of their 
fluorescent light.  
In 1897- Richard Meyer, a German chemist, introduced the term 
"fluorophores" for chemical groups with which fluorescence was associated.  
In 1908- In Heinrich Kayser´s "Handbuch der Spectroscopie, vol. 4" 
Heinrich Knoen, a German physicist, arranged 1700 fluorescent compounds 
alphabetically with references to literature.  
In 1911, 1913 - The first fluorescence microscope was developed by O. 
Heimstaedt, a German physicist, (1911) and H. Lehmann, a German physicist, 
(1913) as an outgrowth of the UV microscope (1901-1904). The instrument was 
used to investigate the autofluorescence of bacteria, protozoa, plant and animal 
tissues, and bio-organic substances such as albumin, elastin, and keratin.  
In 1914- S. Von Provazek, a German protozoologist employed the 
fluorescence microscope to study dye binding to living cells. He stated that 
fluorochromes introduced into the cell effectively illuminate the partial 
functions of the cell in the dark field of the fluorescence microscope. This was a 
giant step forward in experimental cytology.  
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In 1929- Philipp Ellinger, a German pharmacologist, and August Hirt, a 
German anatomist, modified the fluorescence microscope so that it could be 
used to examine opaque specimens from most living organs. The new 
instrument was called an "intravital microscope" and is considered as the first 
epi-fluoresence (or incident-light excitation) microscope. 
Fluorescence: The Phenomenon: 
 Fluorescence is the phenomenon in which absorption of light of a given 
wavelength by a fluorescent molecule is followed by the emission of light at 
longer wavelengths.  
The distribution of wavelength-dependent intensity that causes 
fluorescence is known as the fluorescence excitation spectrum, and the 
distribution of wavelength-dependent intensity of emitted energy is known as 
the fluorescence emission spectrum. 
 Fluorescence detection has three major advantages over other light-
based investigation methods: high sensitivity, high speed, and safety. The point 
of safety refers to the fact that samples are not affected or destroyed in the 
process, and no hazardous byproducts are generated. 
 Sensitivity is an important issue because the fluorescence signal is 
proportional to the concentration of the substance being investigated. Relatively 
small changes in ion concentration in living cells can have significant 
physiological effects. Whereas absorbance measurements can reliably 
determine concentrations only as low as several tenths of a micromolar, 
fluorescence techniques can accurately measure one million times smaller - 
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pico- and even femto-molar concentrations. Quantities less than an attomole 
(<10-18 mole) may be detected. 
 Using fluorescence, one can monitor very rapid changes in 
concentration. Changes in fluorescence intensity on the order of picoseconds can 
be detected if necessary. 
 Because it is a non-invasive technique, fluorescence does not interfere 
with a sample. The excitation light levels required to generate a fluorescence 
signal are low, reducing the effects of photo-bleaching, and living tissue can be 
investigated with no adverse effects on its natural physiological behavior. 
Fluorescence Lifetime Applications: 
 In the last twenty years, fluorescence spectroscopy has evolved into a 
powerful tool for the study of chemical, semiconductor, photochemical, and 
biochemical species. It can provide insight into such intimate processes as 
solvent-solute interactions, the structure and dynamics of nucleic acids, and the 
permeability of membranes. 
 Many of these measurements are made possible by the fluorescence 
lifetime, the average time that a molecule spends in the excited state before 
emitting a photon and returning to the ground state. It is an important and 
unique feature of an excited state. 
 The lifetime of fluorescence is very short. Most fluorescence lifetimes fall 
within the range of hundreds of picoseconds to hundreds of nanoseconds. The 
fluorescence lifetime can function as a molecular stopwatch, to observe a 
variety of interesting molecular events. An antibody may rotate slightly within 
its molecular environment. A protein can change orientation. A critical binding 
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reaction may occur. Because the time-scale of these events is similar to the 
fluorescence lifetime, the measurement of the fluorescence lifetime allows the 
researcher to peer into the molecule and observe these phenomena. 
Uses of Autofluorescence in Biochemistry and Medicine: 
• Protein structure and folding 
• Protein-antibody interactions 
• Donor-acceptor distances 
• Enzyme conformation in proteins and membranes 
• Dynamics and structure of membranes 
• Permeability and ion transport in membranes 
• Lipid dynamics in membranes 
• Dynamics and structure of nucleic acids 
• Photochemistry of vision 
• Mechanism of photosynthesis 
• Photodynamic therapy 
Studies on autofluorescence techniques: 
Liang et al (2000) 181 reported that most of the emissions are due to 
excitation of tryptophan residues, with a few emissions due to residues of 
tyrosine and phenyl alanine. Due to the higher fluorescence quantum yield of 
tryptophan, resonance energy transfer from proximal phenyl alanine to 
tyrosine and from tyrosine to tryptophan, the emission spectrum of tissues 
containing the three residues usually resembles that of tryptophan. Further, the 
photochemical characteristics of tryptophan are very much dependent on its 
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microenvironmental conditions. In particular, the emission of tryptophan 
depends upon its solvent polarity. The fluorescence spectrum shifts to shorter 
wavelength as the polarity of the solvents surrounding the tryptophan residues 
decreases. 
Ueda Y and Kobayashi M. et al (2004) 182 observed that as the lactic-acid 
concentration becomes dense, the AF peak intensity from elastin and desmosine 
solutions become wholly weak. They found a similar reduction in the 
autofluorescence intensity for nicotinamide adenine dinucleotide (NADH) 
solutions. Their analysis indicated that the lactic acid causes the conformational 
change in elastin and the oxidation of NADH, which can be related to changes in 
the AF properties. 
Autofluorescence in oral carcinoma: 
Kolli VR et al (1995) 183, Chen CT et al (1996) 184, Dhingra JK et al (1996) 
185, Ganesan S et al (1998)186, Vengadasan et al (1998) 187, Chen CT et al (1998) 
184, Gillenwater A et al (1998) 188, Lezlee Coghlan et al (2001) 189,  Wei Zheng et al 
(2002) 190, Madhuri S et al (2003) 191, Diana C.G, de Veld et al (2003) 192 and 
Majumder. S. K et al (2003) 193 have reported various findings of 
autofluorescence in pre-cancer and oral cancer.. 
Autofluorescence of oral submucous fibrosis: 
Hsin-ming chen et al (2003) 194 measured the in vivo autofluorescence 
spectra of 59 oral submucous fibrosis mucosal sites and compared the measured 
spectra with autofluorescence spectra obtained from 15 normal oral mucosal 
samples from 15 healthy volunteers, 5 samples of frictional keratosis on OSF 
(FHOSF) buccal mucosa and 29 samples of oral leukoplakia on OSF (OLOSF) 
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buccal mucosa. They found that the spectrum of the OSF mucosa had a 
significantly higher 380nm emission peak and a significantly lower 460nm 
emission peak than the spectra of NOM, FHOSF and OLOSF samples. They 
concluded that OSF has a very unique pattern of autofluorescence spectrum 
which can be used for real-time diagnosis of OSF. 
Tsai T et al (2003) 195 assessed the utility of autofluorescence as a 
diagnostic tool for oral squamous cell carcinoma in a high risk population. They 
characterized the in vivo autofluorescence spectra from oral submucous fibrosis 
(OSF) lesions and oral premalignant and malignant lesions in both OSF and 
non-OSF patients. The mean ratio values increased gradually from OSF to 
NOM, to EH and ED, and to SCC. Their ANOVA test showed significant 
differences in the ratio value among all categories of samples (P<0.01). They 
found that EH, ED, and SCC lesions on OSF patients had distorted 
autofluorescence intensity because of collagen. While the mean ratio values of 
EH, ED, and SCC between non-OSF and OSF patients showed significant 
differences. 
Wang CY et al (2003) 196 used a fiber optics-based fluorospectrometer to 
measure the autofluorescence spectra from healthy volunteers (NOM) and 
patients with oral lesions of submucous fibrosis (OSF), epithelial hyperkeratosis 
(EH), epithelial dysplasia (ED), and squamous cell carcinoma (SCC). They 
concluded that the PLS-ANN classification algorithm based on autofluorescence 
spectroscopy at 330-nm excitation is useful for in vivo diagnosis of OSF as well 
as oral premalignant and malignant lesions. 
Electron microscopical findings: 
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Zorzetto (2002) 197, 198 studied the ultrastructural features of the cheek 
oral mucosa of rats (Rattus norvegicus) submitted to experimental chronic 
alcoholism by transmission electron microscopy. Samples of the oral mucosa 
from the cheek region were dissected and processed for ultrastructural analysis. 
The results showed cell alterations in the basal and intermediate layer of the 
mucosal epithelium. The most frequent alterations observed were an increased 
intercellular space, the presence of lipid droplets in the cytoplasm, and irregular 
nuclei with a pyknotic aspect. 
Cheng LH and Hudson J (2002) 199 have used Transmission electron 
microscopy (TEM) to identify the ultrastructural details of normal and 
cancerous human oral mucosa and features of dysplasia for diagnostic 
purposes. Normal mucosa, severe dysplasia, oral SCC and normal margin 
adjacent to oral SCC were used to compare the ultrastructural features of 
normal and premalignant oral mucosa and oral SCC. Thin and discontinuous 
basal laminas were found in mucosa with severe dysplasia and normal margin 
adjacent to oral SCC. No basal lamina was identified in oral SCC. This study 
showed that there are some ultrastructural changes during malignant 
transformation of oral mucosa.  
Kannan et al (1996) 200 assessed 15 biopsies sampled from the immediate 
adjacent epithelium of oral squamous cell carcinoma, under light and electron 
microscopy. Light microscopic examination of one micron thick sections 
revealed that the majority of lesions (67%) had hyperplastic or mildly dysplastic 
epithelium while the remaining (33%) had moderate to severe dysplasia. 
Ultrastructural observations showed that all these lesions had subcellular 
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alterations similar to those seen in frank malignant oral tissue, particularly in 
the lower half of the epithelium. Important ultrastructural changes observed 
included bizarre nuclei of basal and lower spinal cells, enlarged and multiple 
nucleoli, presence of inter-chromatin and perichromatin granules, loss of 
desmosomes and marked spongiosis as well as disturbed cellular maturation 
sequences in the keratinocytes evidenced by abnormal and irregular 
distribution of maturation markers such as keratohyalin granules and 
tonofilaments.  
Kartha et al (1994) 201 studied the biopsies of twenty-five oral carcinomas 
and five normal oral epithelium, using light and electron microscopy. All 
histological types (well differentiated squamous cell carcinoma, moderately 
differentiated squamous cell carcinoma, poorly differentiated squamous cell 
carcinoma, verrucous carcinoma and spindle cell carcinoma) were seen in the 
study sample. In addition, 1 case of carcinoma in situ was also present. The 
normal oral epithelium consisted of three keratinizing types (gingiva) and two 
non-keratinizing types (buccal mucosa). The ultrastructural features of oral 
carcinomas showed good correlation with the features seen in light microscopy. 
The differentiation status of the lesions showed a relationship with cell and 
nuclear size, tonofilament and keratin content as well as few other cellular 
abnormalities. It was also observed that the fine details revealed by electron 
microscopy were often a means of explaining the characteristic 
histopathological features of oral carcinoma 
Saito H and Itoh I (1993) 202 observed the ultrastructure on the upper and 
lower surfaces of buccal epithelial superficial layer cells and the arrangement of 
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intercellular junction apparatuses by scanning and transmission electron 
microscopy. In the superficial layer cells of the rabbit buccal epithelium, 
microvillus-like processes were observed on the lower surface and micro ridges 
on the upper surface. The distal portion of the microvillus-like process on the 
lower cell surface formed a wedge-like structure. At the inter-micro ridge areas 
on the upper cell surface, wedge-like depressions were observed. These 
depressions were interdigitated with the wedge-like structures of the 
microvillus-like processes. From the observation of the serial ultrathin sections, 
most interdigitation sites have two desmosomes per microvillus-like process 
(89.5%). The desmosomes were located in the distal portion of the microvillus-
like processes (99.3%). The wedge-like structures of the microvillus-like 
processes and wedge-like depressions on the inter-micro ridge areas seem to 
increase the junctional surface and enhance cell cohesion against external forces 
from various directions. 
Mascres C and Joly G (1981) 203 studied the action of alcohol on the oral 
mucosa of Sprague-Dawley female rats, histochemically and ultrastructurally. 
In the alcoholic animals, the epithelium was thickened from day 98 on and SS 
and SH groups were detected in the keratin; at this time interval, positive acid 
phosphatase areas were noted. Under the electron microscope, myelin figures 
were observed and phosphatase areas were noted. Under the electron 
microscope, myelin figures were observed between cells on days 98 and 200. 
Cells undergoing autolysis could explain the lysosomal enzyme activity; the 
DNA activity assessed by methyl-pyronine green stain was increased after 200 
and 290 days. This activity was correlated at these time intervals with the 
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increase of the mitosis number; succino-dehydrogenase showed an increased 
activity on days 200 and 290. The mitochondria often of large size showed no 
ultrastructural changes even on day 290; the vessels, already on day 98, then 
on days 200 and 290, showed a decrease in alkaline phosphatase reactivity 
with occasional thinning of the wall. These modifications suggested that alcohol 
was able to modify the integrity of oral mucosa cells in the rat, perhaps by 
modifying the quality of the cell walls. 
McKinney RV Jr, Singh BB (1977) 204 explored the morphologic nature of 
the basement membrane under neoplastic oral mucous membrane and the 
progression of changes associated with dysplasia, carcinoma in situ, and 
invasive carcinoma. They proposed that neoplastic epithelial cells may produce 
a collagenolytic enzyme which is released into the epithelial intercellular spaces. 
This enzyme permeates to the basement membrane, causes breaks in the 
basement membrane, and focal loss of stromal area contiguous with 
intercellular spaces. The neoplastic basal cells develop pseudopodia that 
eventually extend through the breaks in the basement membrane. This concept 
suggests that the basement membrane changes herald the progression of 
carcinoma in situ to invasive carcinoma. 
Gao et al (1995) 205 performed a morphometric analysis of the spinous 
cell in 16 specimens of oral submucous fibrosis (OSF) by using interactive image 
analysis system (IBAS-II). 19 parameters of the size and shape were chosen, and 
compared with normal mucosa, leukoplakia, dysplasia and carcinoma. The 
results indicated that the cell dimensions (area, perimeter, all kinds of diameter) 
and nuclear cytoplasmic ratio in OSF were between normal mucosa and 
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dysplasia as well as carcinoma. The former showed a progressive decrease (P < 
0.01), and the latter showed a progressive increase (P < 0.01). The dimensions 
of the nuclei did not show considerable differences among the groups (P < 0.05). 
The decrease of cell area and the increase of nuclear cytoplasmic ratio could 
reflect a malignant progress. The cell morphometric model could discriminate 
OSF well from other groups, suggesting that the change of the epithelium in OSF 
appearing in the spinous cell is specific itself. 
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MATERIALS AND METHODS 
5o patients from the Department of Oral Medicine and Radiology of 
Saveetha Dental College and Hospitals, Chennai were taken for the present 
study.  
The patients were categorized into the following groups, 
• GROUP I: 10 patients between the age group of 16 to 60 years, without 
the habits of smoking or alcoholism or pan chewing and without any oral 
lesions, as the controls. 
• GROUP II: 10 patients between the age group of 16 to 60 years, with the 
habit of pan chewing (10-15 quid’s per day) for about 5-10 years, without 
any oral lesions. 
• GROUP III: 10 patients between the age group of 16 – 60 years, with the 
habits of smoking more than 10 cigarettes per day for about 5-10 years, 
without any oral lesions. 
• GROUP IV: 5 patients with homogeneous leukoplakia involving the 
buccal mucosa. 
• GROUP   V:  5 patients with oral sub mucous fibrosis 
• GROUP VI: 5 patients with well differentiated squamous cell carcinoma 
involving the buccal mucosa and alveolar ridge. 
• GROUP VII: 5 patients with moderately differentiated squamous cell 
carcinoma involving the buccal mucosa and alveolar ridge. 
• GROUP VIII: 5 patients with verrucous carcinoma. 
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2. Autofluorescence technique: 
Fluorescence spectroscopy was carried out using FLUOROMAX-2 (USA, 
1996) in the Department of Medical physics at Anna University, Chennai. 
In vivo fluorescence spectroscopy: 
After clinical diagnosis, the patients of group I, II and III were taken to 
the Department of Medical Physics, Anna University, Chennai for in-vivo 
fluorescence spectroscopy. 
The patient was seated comfortably in a chair. Fiber-optic probe 
attached to spectrofluorometer was placed in contact with the mucosa to record 
the data.  
Readings in case of pan chewers were taken from the area where the 
quid was placed. Readings from the control group were taken from an area 
adjacent to the premolars at occlusal level.  
Autofluorescence spectroscopy consists of two procedures: 
1. Excitation spectroscopy. 
2. Emission spectroscopy. 
In excitation spectroscopy, the tissues are excited at a particular 
wavelength and the resulting emissions from the tissues are measured. In the 
present study, excitation spectroscopy was performed at 280 and 320nm 
respectively. 
The second part consists of emission spectroscopy. Emission spectroscopy 
is a complementary technique, performed to confirm the findings of excitation 
spectroscopy and also to observe any conformational changes in the tissues. 
Emission spectroscopy was performed at 340 and 390nm excitation. 
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BIOPSY: 
Subsequent to the autofluorescence spectroscopy, after taking informed 
consent, incisional biopsy was performed from test groups (n=5) and controls 
(n=5) under local anesthesia and the specimen was sent for histopathological 
evaluation and transmission electron microscopy. 
Histopathological procedures:  
The biopsy samples were rinsed in saline and then fixed with 10% 
buffered formalin solution. The tissue was processed routinely and embedded in 
paraffin. 4µ sections were prepared with a Leica semi-automated microtome 
(RM 2245).  
Routine Hematoxylin and Eosin staining was done for microscopic 
examination of the sections. Sections were also prepared for special staining 
procedures to demonstrate collagen. These slides were stained with Van Gieson 
stain to demonstrate collagen in the tissue.  
Staining protocol: Van Gieson Technique: (Van Gieson 1899) 
Solution: 
Saturated aqueous picric acid solution 50 ml 
1% aqueous acid fuchsin solution  9 ml 
Distilled water    50 ml 
Method: 
1. Deparaffinize sections and bring to water. 
2. Stain nuclei with Hematoxylin 
3. Wash in tap water 
4. Differentiate in acid alcohol 
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5. Wash well in tap water 
6. Stain in van Gieson solution for 3 minutes 
7. Blot and dehydrate through alcohols. 
8. Clear in xylene and mount in DPX. 
Histological assessment was performed on the study samples (n= 15) and 
controls (n=25). The samples were grouped into, 
• C1 to C5 = positive controls – patients who are non-users of tobacco 
• S1 to S5 = smokers 
• P1 to P5 = pan chewers 
• L1 to L5 = leukoplakia 
• F1 to F5 = sub mucous fibrosis 
• W1 to W5 = negative controls - well differentiated squamous cell 
carcinoma 
• M1 to M5 = negative controls - moderately differentiated squamous cell 
carcinoma 
• V1 to V5 = negative controls - verrucous carcinoma 
The parameters that were assessed, 
1. Keratinization – ortho(o) /para (p) /non-keratinized (n) 
2. Thickness – atrophy (a) /hyperplastic (h) /normal(n) 
3. Epithelium - connective tissue interface: - normal (n)/ thickened (t)/ 
discontinuous (d) 
Connective tissue – sub-epithelial region: 
4. Density – minimal (1)/ moderate (2)/ increased (3) 
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5. Pattern – wavy (w)/ bundles(b)/ haphazard (m)/ parallel (p)/ stream (s) 
6. Fibroblasts - minimal (1)/ moderate (2)/ increased (3) 
7. Inflammatory cells - absent (0)/minimal (1)/ moderate (2)/ intense (3) 
8. Hyalinization – present (h)/ absent (n) 
9. Vascularity - minimal (1)/ moderate (2)/ intense (3) 
Connective tissue – deeper region: 
10. Density – minimal (1)/ moderate (2)/ increased (3) 
11. Pattern – wavy (w)/ bundles(b)/ haphazard (m)/ parallel (p)/ stream (s) 
12. Fibroblasts - minimal (1)/ moderate (2)/ increased (3) 
13. Inflammatory cells - absent (0)/minimal (1)/ moderate (2)/ intense (3) 
14. Hyalinization – present (h)/ absent (n) 
15. Vascularity - minimal (1)/ moderate (2)/ intense (3) 
16. Dysplasia – absent (o)/ present (d) 
17. Malignant islands – absent (0)/ present (1) 
18. Connective tissue status - homogenous (h)/ lysis (l) 
19. Van Gieson stain intensity - minimal (1)/ moderate (2)/ intense (3) 
Electron microscopy: 
Five representative samples were fixed in glutaraldehyde, processed and 
subjected to transmission electron microscopy. The protocol is as follows, 
1. The tissue samples were fixed with 2.5% buffered glutaraldehyde at 
4oC overnight. 
2. It was then washed with cacodylate buffer (pH-7.2) for 15 minutes. 
3. Post fixation was done with 1% buffered osmium tetroxide for 2 hours 
at 4oC 
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4. Washed in buffer for 10 minutes. 
5. Dehydrated in ascending grades of alcohol (30%, 50%, 70%, 80%, 
90% and 100%) for 10 minutes in each concentration. 
6. Treated with propylene oxide for 10 minutes. 
7. Infiltrated with resin-propylene oxide mixture in the ratio – 1:3 
initially for two hours, later reverted to 3:1 ratio for two hours and 
finally in 100% resin for two hours. 
8. Embedded with epoxy resin (EPON 812 polar bed resin) with catalyst 
and incubated at 60oC for 48 hours. 
9. Blocks were made, serial sections done and stained with toluidine blue 
for light microscopy. 
10.  The site was located on light microscopy and sections of 1 micron 
thickness was prepared with Leica ultracut microtome. 
11. Silver grey sections were collected on copper grids and stained with 
saturated solution of uranyl acetate and lead citrate. 
12.  Sections were scanned with JEOL 100 SX electron microscope with 
an acceleration voltage of 60 to 80 KV. 
13. Selected areas were then photographed. 
 
All the parameters were tabulated as shown in the master chart (fig.1) and 
the data were fed into a computer and the statistical significance was assessed 
with SPSS Version 10. 
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Histological assessment of the samples: 
 
Comparison of Controls, Smokers and Pan Chewers: 
 
Group * Keratinization 
Crosstab
2 3 5
40.0% 60.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
5 5
100.0% 100.0%
2 12 1 15
13.3% 80.0% 6.7% 100.0%
Count
% within Gro
Count
% within Gro
Count
% within Gro
Count
% within Gro
C
S
P
Group
Total
O P N
Keratinisation
Total
 
Chi-Square Tests
6.500a 4 .165
7.097 4 .131
1.909 1 .167
15
Pearson Chi-Sq
Likelihood Ratio
Linear-by-Linea
Association
N of Valid Case
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count les
minimum expected count is .33.
a. 
 
 
 
 
 
Group * Thickness 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
15 15
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
Group
Total
H
Thicknes
s
Total
  
 
 
Group * Interface 
Crosstab
3 2 5
60.0% 40.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
10 5 15
66.7% 33.3% 100.0%
Count
% within Gro
Count
% within Gro
Count
% within Gro
Count
% within Gro
C
S
P
Group
Total
N T
Interface
Total
 
Chi-Square Tests
.600a 2 .741
.631 2 .729
.420 1 .517
15
Pearson Chi-Sq
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less
minimum expected count is 1.67.
a. 
 
Chi-Square Tests 
. a
15 
Pearson Chi-Square
N of Valid Cases
Value 
No statistics are computed 
because Thickness is a constant. 
a. 
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Group * Connective tissue - Subepithelial - Density 
 
Chi-Square Tests
2.400a 4 .663
2.634 4 .621
1.135 1 .287
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less than 5. The
minimum expected count is .33.
a. 
 
 
 
Group * Connective tissue - Subepithelial - Pattern 
 
Chi-Square Tests
6.000a 4 .199
8.488 4 .075
.108 1 .742
15
Pearson Chi-Squ
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less 
minimum expected count is .67.
a. 
 
 
Group * Connective tissue- Subepithelial - Fibroblasts 
Crosstab
4 1 5
80.0% 20.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
5 5
100.0% 100.0%
12 3 15
80.0% 20.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
Group
Total
+ ++
CT - Subep -
Fibroblasts
Total
 
Chi-Square Tests
2.500a 2 .287
3.278 2 .194
.583 1 .445
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less than 5. T
minimum expected count is 1.00.
a. 
 
 
Group * Connective tissue - Subepithelial – Inflammatory cells 
Crosstab
3 2 5
60.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
3 10 2 15
20.0% 66.7% 13.3% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
Group
Total
- + ++
CT - Subep - Inflammatory
Total
 
Chi-Square Tests
7.800a 4 .099
9.087 4 .059
4.541 1 .033
15
Pearson Chi-Squa
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less than
minimum expected count is .67.
a. 
 
 
 
 
 
 
 
Crosstab 
1 3 1 5
20.0% 60.0% 20.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
5 9 1 15
33.3% 60.0% 6.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C 
S 
P 
Group
Total
+ ++ +++
CT - Subep - Density
Total
Crosstab
3 1 1 5
60.0% 20.0% 20.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
6 2 7 15
40.0% 13.3% 46.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C 
S 
P 
Group
Total
Wavy Bundles Haphazard
CT - Subep - Pattern
Total
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Group * Connective tissue - Subepithelial - Hyalinization 
 
Chi-Square Tests
.a
15
Pearson Chi-Squa
N of Valid Cases
Value
No statistics are computed because
- Subep - Hyalinisation is a constant
a. 
 
 
 
Group * Connective tissue - Subepithelial - Vascularity 
Crosstab
3 2 5
60.0% 40.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
9 6 15
60.0% 40.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
Group
Total
+ ++
CT - Subep -
Vascularity
Total
 
Chi-Square Tests
1.667a 2 .435
1.726 2 .422
.389 1 .533
15
Pearson Chi-Squ
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less th
minimum expected count is 2.00.
a. 
 
 
Group * Connective tissue – Deeper region - Density 
 
Chi-Square Tests
7.000a 4 .136
7.442 4 .114
4.773 1 .029
15
Pearson Chi-Squar
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less than 5. 
minimum expected count is .67.
a. 
 
 
Group * Connective tissue - Deep - Pattern 
 
Chi-Square Tests
6.100a 4 .192
6.820 4 .146
.128 1 .720
15
Pearson Chi-Squ
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less th
minimum expected count is 1.33.
a. 
 
 
 
 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
15 15
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C 
S 
P 
Group
Total
Negative
CT -
Subep -
Hyalinization
 
Total
Crosstab 
1 2 2 5
20.0% 40.0% 40.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
7 6 2 15
46.7% 40.0% 13.3% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
Group
Total
+ ++ +++
CT - Deep - Density
Total
Crosstab
1 3 1 5
20.0% 60.0% 20.0% 100.0%
1 1 3 5
20.0% 20.0% 60.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
5 4 6 15
33.3% 26.7% 40.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C 
S 
P 
Group
Total
Wavy Bundles Haphazard
CT - Deep - Pattern
Total
 72
Group * Connective tissue - Deep - Fibroblasts 
Crosstab
4 1 5
80.0% 20.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
14 1 15
93.3% 6.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
Group
Total
+ ++
CT - Deep -
Fibroblasts
Total
 
Chi-Square Tests
2.143a 2 .343
2.344 2 .310
1.500 1 .221
15
Pearson Chi-Squa
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less tha
minimum expected count is .33.
a. 
 
 
 
 
Group * Connective tissue - Deep - Inflammatory 
Crosstab
3 2 5
60.0% 40.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
1 3 1 5
20.0% 60.0% 20.0% 100.0%
4 7 3 1 15
26.7% 46.7% 20.0% 6.7% 100.0%
Count
% within Grou
Count
% within Grou
Count
% within Grou
Count
% within Grou
C
S
P
Group
Total
- + ++ +++
CT - Deep - Inflammatory
Total
 
Chi-Square Tests
13.500a 6 .036
15.080 6 .020
8.195 1 .004
15
Pearson Chi-Squ
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (100.0%) have expected count less 
minimum expected count is .33.
a. 
 
 
Group * Connective tissue - Deep - Hyalinization 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
15 15
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
Group
Total
Negative
CT -
Deep -
Hyalinisat
ion
Total
 
Chi-Square Tests
.a
15
Pearson Chi-Squa
N of Valid Cases
Value
No statistics are computed becaus
- Deep - Hyalinisation is a constant
a. 
 
Group * Connective tissue - Deep - Vascularity 
Crosstab
2 3 5
40.0% 60.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
8 7 15
53.3% 46.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
Group
Total
+ ++
CT - Deep - Vascularity
Total
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Chi-Square Tests
.536a 2 .765
.537 2 .764
.375 1 .540
15
Pearson Chi-Squa
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less than
minimum expected count is 2.33.
a. 
 
Group * Dysplasia 
 
Chi-Square Tests
.a
15
Pearson Chi-Square
N of Valid Cases
Value
No statistics are computed
because Dysplatia is a constant
a. 
 
Group * Malignant Islands 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
15 15
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
Group
Total
-
Malignant
Islands
Total
 
Chi-Square Tests
.a
15
Pearson Chi-Square
N of Valid Cases
Value
No statistics are computed because
Malignant Islands is a constant.
a. 
 
 
 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
15 15
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C 
S
P
Group
Total
-
Dysplasia
Total
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Group * Status of connective tissue - Homogenous / Lysis 
Crosstab
5 5
100.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
5 5
100.0% 100.0%
12 3 15
80.0% 20.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
Group
Total
H L
Homogenous / Lysis
Total
 
Chi-Square Tests
7.500a 2 .024
8.282 2 .016
.000 1 1.000
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.00.
a. 
 
Group * Vangieson 
Crosstab
1 4 5
20.0% 80.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
2 12 1 15
13.3% 80.0% 6.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
Group
Total
+ ++ +++
Vangieson
Total
Chi-Square Tests
3.000a 4 .558
3.819 4 .431
.000 1 1.000
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less than 5. The
minimum expected count is .33.
a. 
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Comparison of Controls, Smokers, Pan chewers, Leukoplakia, Sub mucous fibrosis, Well 
differentiated squamous cell carcinoma, Moderately differentiated squamous cell 
carcinoma and Verrucous carcinoma: 
 
Group * Keratinization 
Crosstab
2 3 5
40.0% 60.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 34 1 40
12.5% 85.0% 2.5% 100.0%
Count
% within Gro
Count
% within Gro
Count
% within Gro
Count
% within Gro
Count
% within Gro
Count
% within Gro
Count
% within Gro
Count
% within Gro
Count
% within Gro
C
S
P
L
F
W
M
V
Group
Total
O P N
Keratinisation
Total
 
Chi-Square Tests
25.035a 14 .034
20.759 14 .108
.298 1 .585
40
Pearson Chi-Squ
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
24 cells (100.0%) have expected count less
minimum expected count is .13.
a. 
 
 
 
Group * Thickness 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 35 40
12.5% 87.5% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
F
W
M
V
Group
Total
A H
Thickness
Total
 
Chi-Square Tests
40.000a 7 .000
30.142 7 .000
.265 1 .606
40
Pearson Chi-S
Likelihood Rati
Linear-by-Linea
Association
N of Valid Case
Value df
Asymp. Sig
(2-sided)
16 cells (100.0%) have expected count
minimum expected count is .63.
a. 
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Group * Interface 
Crosstab
3 2 5
60.0% 40.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
24 6 10 40
60.0% 15.0% 25.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
F
W
M
V
Group
Total
N T D
Interface
Total
Chi-Square Tests
46.667a 14 .000
51.543 14 .000
4.314 1 .038
40
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
24 cells (100.0%) have expected count less than 5. The
minimum expected count is .75.
a. 
 
 
 
Group * Connective tissue - Subepithelial - Density 
Crosstab
1 3 1 5
20.0% 60.0% 20.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
26 13 1 40
65.0% 32.5% 2.5% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
F
W
M
V
Group
Total
+ ++ +++
CT - Subep - Dentity
Total
 
Chi-Square Tests
22.769a 14 .064
24.304 14 .042
13.261 1 .000
40
Pearson Chi-Squa
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
24 cells (100.0%) have expected count less th
minimum expected count is .13.
a. 
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Group * Connective tissue - Subepithelial - Pattern 
 
Chi-Square Tests
65.333a 28 .000
49.678 28 .007
9.034 1 .003
40
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
40 cells (100.0%) have expected count less than 5. The
minimum expected count is .25.
a. 
  
 
Group * Connective tissue - Subepithelial – Fibroblasts: 
Crosstab
4 1 5
80.0% 20.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
5 5
100.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
27 13 40
67.5% 32.5% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
F
W
M
V
Group
Total
+ ++
CT - Subep -
Fibroblasts
Total
 
Chi-Square Tests
7.179a 7 .410
8.514 7 .289
2.799 1 .094
40
Pearson Chi-Squ
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
16 cells (100.0%) have expected count less 
minimum expected count is 1.63.
a. 
 
 
 
Crosstab
3 1 1 5
60.0% 20.0% 20.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
5 5
100.0% 100.0%
8 2 24 4 2 40
20.0% 5.0% 60.0% 10.0% 5.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C 
S 
P 
L 
F 
W
M 
V 
Group
Total
Wavy Bundles Haphazard Parallel Stream
CT - Subep - Pattern
Total 
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Group * Connective tissue - Subepithelial – Inflammatory cells 
Crosstab
3 2 5
60.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
1 3 1 5
20.0% 60.0% 20.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
3 17 8 12 40
7.5% 42.5% 20.0% 30.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
F
W
M
V
Group
Total
- + ++ +++
CT - Subep - Inflammatory
Total
 
Chi-Square Tests
52.000a 21 .000
49.571 21 .000
15.611 1 .000
40
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
32 cells (100.0%) have expected count less than 5. The
minimum expected count is .38.
a. 
 
 
Group * Connective tissue - Subepithelial - Hyalinization 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
3 37 40
7.5% 92.5% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
F
W
M
V
Group
Total
Present Negative
CT - Subep -
Hyalinisation
Total
 
Chi-Square Tests
22.703a 7 .002
14.581 7 .042
.151 1 .698
40
Pearson Chi-Sq
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
16 cells (100.0%) have expected count les
minimum expected count is .38.
a. 
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Group * Connective tissue - Subepithelial - Vascularity 
Crosstab
3 2 5
60.0% 40.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
2 2 1 5
40.0% 40.0% 20.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
1 3 1 5
20.0% 60.0% 20.0% 100.0%
24 14 2 40
60.0% 35.0% 5.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
F
W
M
V
Group
Total
+ ++ +++
CT - Subep - Vascularity
Total
 
Chi-Square Tests
12.476a 14 .568
12.369 14 .577
.214 1 .644
40
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
24 cells (100.0%) have expected count less than 5. The
minimum expected count is .25.
a. 
 
Group * Connective tissue - Deep - Density 
Crosstab
1 2 2 5
20.0% 40.0% 40.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
5 5
100.0% 100.0%
25 13 2 40
62.5% 32.5% 5.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
F
W
M
V
Group
Total
+ ++ +++
CT - Deep - Dentity
Total
 
Chi-Square Tests
22.966a 14 .061
18.954 14 .167
7.445 1 .006
40
Pearson Chi-Sq
Likelihood Ratio
Linear-by-Linea
Association
N of Valid Case
Value df
Asymp. Sig
(2-sided)
24 cells (100.0%) have expected count
minimum expected count is .25.
a. 
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Group * Connective tissue - Deep - Pattern 
 
Chi-Square Tests
41.968a 21 .004
33.556 21 .040
9.333 1 .002
40
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
32 cells (100.0%) have expected count less than 5. The
minimum expected count is .25.
a. 
 
Group * Connective tissue - Deep - Fibroblasts 
Crosstab
4 1 5
80.0% 20.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
28 12 40
70.0% 30.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
F
W
M
V
Group
Total
+ ++
CT - Deep -
Fibroblasts
Total
 
Chi-Square Tests
17.143a 7 .016
20.397 7 .005
9.750 1 .002
40
Pearson Chi-S
Likelihood Rat
Linear-by-Line
Association
N of Valid Cas
Value df
Asymp. Sig
(2-sided)
16 cells (100.0%) have expected cou
minimum expected count is 1.50.
a. 
 
 
Crosstab
1 3 1 5
20.0% 60.0% 20.0% 100.0%
1 1 3 5
20.0% 20.0% 60.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
5 5
100.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
5 5
100.0% 100.0%
7 4 27 2 40 
17.5% 10.0% 67.5% 5.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C 
S
P
L
F
W
M
V
Group 
Total 
Wavy Bundles Haphazard Stream
CT - Deep - Pattern
Total
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Group * Connective tissue - Deep - Inflammatory 
Crosstab
3 2 5
60.0% 40.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
1 3 1 5
20.0% 60.0% 20.0% 100.0%
3 1 1 5
60.0% 20.0% 20.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
1 2 2 5
20.0% 40.0% 40.0% 100.0%
4 15 12 9 40
10.0% 37.5% 30.0% 22.5% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
F
W
M
V
Group
Total
- + ++ +++
CT - Deep - Inflammatory
Total
 
Chi-Square Tests
44.978a 21 .002
45.564 21 .001
14.862 1 .000
40
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
32 cells (100.0%) have expected count less than 5. The
minimum expected count is .50.
a. 
 
 
Group * Connective tissue - Deep – Hyalinization 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
40 40
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
F
W
M
V
Group
Total
Negative
CT -
Deep -
Hyalinisat
ion
Total
 
Chi-Square Tests
.a
40
Pearson Chi-Squa
N of Valid Cases
Value
No statistics are computed becaus
- Deep - Hyalinisation is a constant
a. 
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Group * Connective tissue - Deep - Vascularity 
Crosstab
2 3 5
40.0% 60.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
3 1 1 5
60.0% 20.0% 20.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
23 16 1 40
57.5% 40.0% 2.5% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
F
W
M
V
Group
Total
+ ++ +++
CT - Deep - Vascularity
Total
 
Chi-Square Tests
11.696a 14 .631
8.993 14 .831
.000 1 1.000
40
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
24 cells (100.0%) have expected count less than 5. The
minimum expected count is .13.
a. 
 
Group * Dysplasia 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
20 20 40
50.0% 50.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
F
W
M
V
Group
Total
+ -
Dysplatia
Total
 
Chi-Square Tests
40.000a 7 .000
55.452 7 .000
22.750 1 .000
40
Pearson Chi-Squa
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
16 cells (100.0%) have expected count less than
minimum expected count is 2.50.
a. 
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Group * Malignant Islands 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
10 30 40
25.0% 75.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
F
W
M
V
Group
Total
+ -
Malignant Islands
Total
 
Chi-Square Tests
40.000a 7 .000
44.987 7 .000
9.905 1 .002
40
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
16 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.25.
a. 
 
Group * Homogenous / Lysis 
Crosstab
5 5
100.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
5 5
100.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
26 14 40
65.0% 35.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
F
W
M
V
Group
Total
H L
Homogenous / Lysis
Total
 
Chi-Square Tests
13.626a 7 .058
16.593 7 .020
1.653 1 .199
40
Pearson Chi-Squ
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
16 cells (100.0%) have expected count less 
minimum expected count is 1.75.
a. 
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Group * Vangieson 
Crosstab
1 4 5
20.0% 80.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
5 5
100.0% 100.0%
9 26 5 40
22.5% 65.0% 12.5% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
F
W
M
V
Group
Total
+ ++ +++
Vangieson
Total
 
Chi-Square Tests
38.414a 14 .000
33.291 14 .003
.874 1 .350
40
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
24 cells (100.0%) have expected count less than 5. The
minimum expected count is .63.
a. 
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Comparison of Controls, Smokers, Pan chewers and Leukoplakia: 
 
Group * Keratinization 
Crosstab
2 3 5
40.0% 60.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
2 17 1 20
10.0% 85.0% 5.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
Group
Total
O P N
Keratinisation
Total
Chi-Square Tests
9.647a 6 .140
8.993 6 .174
1.610 1 .204
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (100.0%) have expected count less than 5. The
minimum expected count is .25.
a. 
 
 
Group * Thickness 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
20 20
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
Group
Total
H
Thicknes
s
Total
 
Chi-Square Tests
.a
20
Pearson Chi-Squ
N of Valid Cases
Value
No statistics are computed
because Thickness is a const
a. 
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Group * Interface 
Crosstab
3 2 5
60.0% 40.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
14 6 20
70.0% 30.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
Group
Total
N T
Interface
Total
 
Chi-Square Tests
.952a 3 .813
.966 3 .809
.724 1 .395
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
8 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.50.
a. 
 
Group * Connective tissue - Subepithelial - Density 
 
Crosstab
1 3 1 5
20.0% 60.0% 20.0% 100.0% 
2 3 5
40.0% 60.0% 100.0% 
2 3 5
40.0% 60.0% 100.0% 
4 1 5
80.0% 20.0% 100.0% 
9 10 1 20
45.0% 50.0% 5.0% 100.0% 
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
C
S 
P 
L 
Group 
Total 
+ ++ +++
CT - Subep - Density
Total
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Chi-Square Tests
6.311a 6 .389
6.261 6 .395
4.024 1 .045
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (100.0%) have expected count less than 5. The
minimum expected count is .25.
a. 
 
Group * Connective tissue - Subepithelial - Pattern 
 
Chi-Square Tests
8.312a 6 .216
10.819 6 .094
1.105 1 .293
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (100.0%) have expected count less than 5. The
minimum expected count is .50.
a. 
 
Group * Connective tissue - Subepithelial - Fibroblasts 
Crosstab
4 1 5
80.0% 20.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
5 5
100.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
16 4 20
80.0% 20.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
Group
Total
+ ++
CT - Subep -
Fibroblasts
Total
 
Crosstab
3 1 1 5 
60.0% 20.0% 20.0% 100.0% 
1 4 5 
20.0% 80.0% 100.0% 
3 2 5 
60.0% 40.0% 100.0% 
1 4 5 
20.0% 80.0% 100.0% 
7 2 11 20 
35.0% 10.0% 55.0% 100.0% 
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
C 
S
P
L
Group 
Total 
Wavy Bundles Haphazard
CT - Subep - Pattern
Total 
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Chi-Square Tests
2.500a 3 .475
3.278 3 .351
.238 1 .626
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
8 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.00.
a. 
 
 
Group * Connective tissue - Subepithelial - Inflammatory 
Crosstab
3 2 5
60.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
3 11 2 4 20
15.0% 55.0% 10.0% 20.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
Group
Total
- + ++ +++
CT - Subep - Inflammatory
Total
 
Chi-Square Tests
25.455a 9 .003
24.879 9 .003
11.154 1 .001
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
16 cells (100.0%) have expected count less than 5. The
minimum expected count is .50.
a. 
 
Group * Connective tissue - Subepithelial - Hyalinization 
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Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
20 20
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
Group
Total
Negative
CT -
Subep -
Hyalinisat
ion
Total
 
Chi-Square Tests
.a
20
Pearson Chi-Square
N of Valid Cases
Value
No statistics are computed because CT
- Subep - Hyalinisation is a constant.
a. 
 
Group * Connective tissue - Subepithelial - Vascularity 
Crosstab
3 2 5
60.0% 40.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
2 2 1 5
40.0% 40.0% 20.0% 100.0%
11 8 1 20
55.0% 40.0% 5.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
Group
Total
+ ++ +++
CT - Subep - Vascularity
Total
 
Chi-Square Tests
5.000a 6 .544
4.791 6 .571
.434 1 .510
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (100.0%) have expected count less than 5. The
minimum expected count is .25.
a. 
 
Group * Connective tissue - Deep - Density 
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Crosstab
1 2 2 5
20.0% 40.0% 40.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
11 7 2 20
55.0% 35.0% 10.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
Group
Total
+ ++ +++
CT - Deep - Dentity
Total
 
Chi-Square Tests
10.026a 6 .124
9.773 6 .135
6.135 1 .013
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (100.0%) have expected count less than 5. The
minimum expected count is .50.
a. 
 
 
Group * Connective tissue - Deep - Pattern 
 
Chi-Square Tests
10.000a 6 .125
10.447 6 .107
.450 1 .502
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.00.
a. 
 
Crosstab
1 3 1 5
20.0% 60.0% 20.0% 100.0%
1 1 3 5
20.0% 20.0% 60.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
6 4 10 20
30.0% 20.0% 50.0% 100.0%
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
C 
S
P
L
Group 
Total 
Wavy Bundles Haphazard
CT - Deep - Pattern
Total
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Group * Connective tissue - Deep - Fibroblasts 
Crosstab
4 1 5
80.0% 20.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
19 1 20
95.0% 5.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
Group
Total
+ ++
CT - Deep -
Fibroblasts
Total
 
Chi-Square Tests
3.158a 3 .368
2.937 3 .402
1.800 1 .180
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
8 cells (100.0%) have expected count less than 5. The
minimum expected count is .25.
a. 
 
 
 
Group * Connective tissue - Deep - Inflammatory 
Crosstab
3 2 5
60.0% 40.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
1 3 1 5
20.0% 60.0% 20.0% 100.0%
3 1 1 5
60.0% 20.0% 20.0% 100.0%
4 10 4 2 20
20.0% 50.0% 20.0% 10.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
Group
Total
- + ++ +++
CT - Deep - Inflammatory
Total
 
Chi-Square Tests
16.000a 9 .067
18.085 9 .034
7.200 1 .007
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
16 cells (100.0%) have expected count less than 5. The
minimum expected count is .50.
a. 
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Group * CT - Deep - Hyalinization 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
20 20
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
Group
Total
Negative
CT -
Deep -
Hyalinisat
ion
Total
 
Chi-Square Tests
.a
20
Pearson Chi-Square
N of Valid Cases
Value
No statistics are computed because CT
- Deep - Hyalinisation is a constant.
a. 
 
 
Group * Connective tissue - Deep - Vascularity 
Crosstab
2 3 5
40.0% 60.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
3 1 1 5
60.0% 20.0% 20.0% 100.0%
11 8 1 20
55.0% 40.0% 5.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
Group
Total
+ ++ +++
CT - Deep - Vascularity
Total
 
Chi-Square Tests
4.273a 6 .640
4.111 6 .662
.000 1 1.000
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (100.0%) have expected count less than 5. The
minimum expected count is .25.
a. 
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Group * Dysplasia 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 15 20
25.0% 75.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
Group
Total
+ -
Dysplatia
Total
 
Chi-Square Tests
20.000a 3 .000
22.493 3 .000
11.400 1 .001
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
8 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.25.
a. 
 
Group * Malignant Islands 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
20 20
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
Group
Total
-
Malignant
Islands
Total
 
Chi-Square Tests
.a
20
Pearson Chi-Square
N of Valid Cases
Value
No statistics are computed because
Malignant Islands is a constant.
a. 
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Group * Homogenous / Lysis 
Crosstab
5 5
100.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
5 5
100.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
15 5 20
75.0% 25.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
Group
Total
H L
Homogenous / Lysis
Total
Chi-Square Tests
7.200a 3 .066
9.033 3 .029
.456 1 .499
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
8 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.25.
a. 
 
 
Group * Vangieson 
Crosstab
1 4 5
20.0% 80.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
3 16 1 20
15.0% 80.0% 5.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
L
Group
Total
+ ++ +++
Vangieson
Total
 
Chi-Square Tests
4.000a 6 .677
4.499 6 .610
.200 1 .655
20
Pearson Chi-S
Likelihood Rat
Linear-by-Line
Association
N of Valid Cas
Value df
Asymp. Sig
(2-sided)
12 cells (100.0%) have expected coun
minimum expected count is .25.
a. 
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Comparison between Controls, Smokers, Pan chewers and Sub mucous fibrosis: 
Group * Keratinization 
Crosstab
2 3 5
40.0% 60.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
5 5
100.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
5 14 1 20
25.0% 70.0% 5.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
F
Group
Total
O P N
Keratinisation
Total
 
Chi-Square Tests
9.829a 6 .132
11.377 6 .077
1.336 1 .248
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (100.0%) have expected count less than 5. The
minimum expected count is .25.
a. 
 
Group * Thickness 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 15 20
25.0% 75.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
F
Group
Total
A H
Thickness
Total
 
Chi-Square Tests
20.000a 3 .000
22.493 3 .000
14.657 1 .000
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
8 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.25.
a. 
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Group * Interface 
Crosstab
3 2 5
60.0% 40.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
5 5
100.0% 100.0%
15 5 20
75.0% 25.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
F
Group
Total
N T
Interface
Total
 
Chi-Square Tests
2.933a 3 .402
4.029 3 .258
2.613 1 .106
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
8 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.25.
a. 
 
Group * Connective tissue - Subepithelial - Density 
Crosstab
1 3 1 5
20.0% 60.0% 20.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
7 12 1 20
35.0% 60.0% 5.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
F
Group
Total
+ ++ +++
CT - Subep - Dentity
Total
 
Chi-Square Tests
3.429a 6 .753
3.256 6 .776
.858 1 .354
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (100.0%) have expected count less than 5. The
minimum expected count is .25.
a. 
 
 
 
 
 97
Group * Connective tissue - Subepithelial - Pattern 
 
Chi-Square Tests
23.000a 9 .006
24.953 9 .003
7.300 1 .007
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
16 cells (100.0%) have expected count less than 5. The
minimum expected count is .50.
a. 
 
Group * Connective tissue - Subepithelial - Fibroblasts 
Crosstab
4 1 5
80.0% 20.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
5 5
100.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
16 4 20
80.0% 20.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
F
Group
Total
+ ++
CT - Subep -
Fibroblasts
Total
 
Chi-Square Tests
2.500a 3 .475
3.278 3 .351
.136 1 .713
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
8 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.00.
a. 
 
Crosstab
3 1 1 5 
60.0% 20.0% 20.0% 100.0%
1 4 5 
20.0% 80.0% 100.0%
3 2 5 
60.0% 40.0% 100.0%
1 4 5 
20.0% 80.0% 100.0%
6 2 8 4 20 
30.0% 10.0% 40.0% 20.0% 100.0%
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
C 
S 
P 
F
Group 
Total
Wavy Bundles Haphazard Parallel 
CT - Subep - Pattern
Total
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Group * Connective tissue - Subepithelial - Inflammatory 
Crosstab
3 2 5
60.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
3 13 4 20
15.0% 65.0% 20.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
F
Group
Total
- + ++
CT - Subep - Inflammatory
Total
 
Chi-Square Tests
11.846a 6 .065
11.990 6 .062
5.347 1 .021
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (100.0%) have expected count less than 5. The
minimum expected count is .75.
a. 
 
Group * Connective tissue - Subepithelial - Hyalinization 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
3 17 20
15.0% 85.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
F
Group
Total
Present Negative
CT - Subep -
Hyalinisation
Total
 
Chi-Square Tests
10.588a 3 .014
10.178 3 .017
7.760 1 .005
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
8 cells (100.0%) have expected count less than 5. The
minimum expected count is .75.
a. 
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Group * Connective tissue - Subepithelial - Vascularity 
Crosstab
3 2 5
60.0% 40.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
13 7 20
65.0% 35.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
F
Group
Total
+ ++
CT - Subep -
Vascularity
Total
 
Chi-Square Tests
2.418a 3 .490
2.430 3 .488
1.008 1 .315
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
8 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.75.
a. 
 
Group * Connective tissue - Deep - Density 
Crosstab
1 2 2 5
20.0% 40.0% 40.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
9 9 2 20
45.0% 45.0% 10.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
F
Group
Total
+ ++ +++
CT - Deep - Dentity
Total
 
Chi-Square Tests
9.333a 6 .156
8.943 6 .177
1.679 1 .195
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (100.0%) have expected count less than 5. The
minimum expected count is .50.
a. 
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Group * Connective tissue - Deep - Pattern 
 
Chi-Square Tests
12.982a 6 .043
14.155 6 .028
2.760 1 .097
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.00.
a. 
 
Group * Connective tissue - Deep - Fibroblasts 
Crosstab
4 1 5
80.0% 20.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
18 2 20
90.0% 10.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
F
Group
Total
+ ++
CT - Deep -
Fibroblasts
Total
 
Chi-Square Tests
2.222a 3 .528
2.995 3 .392
.060 1 .806
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
8 cells (100.0%) have expected count less than 5. The
minimum expected count is .50.
a. 
 
Crosstab
1 3 1 5
20.0% 60.0% 20.0% 100.0%
1 1 3 5
20.0% 20.0% 60.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
5 5
100.0% 100.0%
5 4 11 20
25.0% 20.0% 55.0% 100.0%
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
C 
S
P
F 
Group 
Total 
Wavy Bundles Haphazard
CT - Deep - Pattern
Total
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Group * Connective tissue - Deep - Inflammatory 
Crosstab
3 2 5
60.0% 40.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
1 3 1 5
20.0% 60.0% 20.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
4 10 5 1 20
20.0% 50.0% 25.0% 5.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
F
Group
Total
- + ++ +++
CT - Deep - Inflammatory
Total
 
Chi-Square Tests
16.400a 9 .059
18.626 9 .029
4.778 1 .029
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
16 cells (100.0%) have expected count less than 5. The
minimum expected count is .25.
a. 
 
Group * Connective tissue - Deep - Hyalinization 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
20 20
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
F
Group
Total
Negative
CT -
Deep -
Hyalinisat
ion
Total
 
Chi-Square Tests
.a
20
Pearson Chi-Square
N of Valid Cases
Value
No statistics are computed because CT
- Deep - Hyalinisation is a constant.
a. 
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Group * Connective tissue - Deep - Vascularity 
Crosstab
2 3 5
40.0% 60.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
12 8 20
60.0% 40.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
F
Group
Total
+ ++
CT - Deep - Vascularity
Total
Chi-Square Tests
1.667a 3 .644
1.726 3 .631
1.448 1 .229
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
8 cells (100.0%) have expected count less than 5. The
minimum expected count is 2.00.
a. 
 
Group * Dysplasia 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
20 20
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
F
Group
Total
-
Dysplatia
Total
 
Chi-Square Tests
.a
20
Pearson Chi-Square
N of Valid Cases
Value
No statistics are computed
because Dysplatia is a constant.
a. 
 
Group * Malignant Islands 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
20 20
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
F
Group
Total
-
Malignant
Islands
Total
 
Chi-Square Tests
.a
20
Pearson Chi-Square
N of Valid Cases
Value
No statistics are computed because
Malignant Islands is a constant.
a. 
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Group * Homogenous / Lysis 
Crosstab
5 5
100.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
5 5
100.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
16 4 20
80.0% 20.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
F
Group
Total
H L
Homogenous / Lysis
Total
Chi-Square Tests
7.500a 3 .058
8.282 3 .041
.000 1 1.000
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
8 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.00.
a. 
 
Group * Vangieson 
Crosstab
1 4 5
20.0% 80.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
2 13 5 20
10.0% 65.0% 25.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
P
F
Group
Total
+ ++ +++
Vangieson
Total
 
Chi-Square Tests
12.677a 6 .048
14.258 6 .027
6.303 1 .012
20
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (100.0%) have expected count less than 5. The
minimum expected count is .50.
a. 
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Comparison between Controls, Smokers and Leukoplakia: 
Group * Keratinization 
Crosstab
2 3 5
40.0% 60.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
5 5
100.0% 100.0%
2 12 1 15
13.3% 80.0% 6.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
L
Group
Total
O P N
Keratinisation
Total
 
Chi-Square Tests
6.500a 4 .165
7.097 4 .131
1.114 1 .291
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less than 5. The
minimum expected count is .33.
a. 
 
Group * Thickness 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
15 15
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
L
Group
Total
H
Thicknes
s
Total
 
Chi-Square Tests
.a
15
Pearson Chi-Sq
N of Valid Case
Value
No statistics are computed
because Thickness is a co
a. 
 
Group * Interface 
Crosstab
3 2 5
60.0% 40.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
10 5 15
66.7% 33.3% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
L
Group
Total
N T
Interface
Total
 
Chi-Square Tests
.600a 2 .741
.631 2 .729
.500 1 .480
15
Pearson Chi-Squa
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less tha
minimum expected count is 1.67.
a. 
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Group * Connective tissue - Subepithelial - Density 
Crosstab
1 3 1 5
20.0% 60.0% 20.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
7 7 1 15
46.7% 46.7% 6.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
L
Group
Total
+ ++ +++
CT - Subep - Dentity
Total
 
Chi-Square Tests
5.143a 4 .273
5.519 4 .238
3.857 1 .050
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less than 5. The
minimum expected count is .33.
a. 
 
Group * Connective tissue - Subepithelial - Pattern 
 
Chi-Square Tests
6.500a 4 .165
8.318 4 .081
2.124 1 .145
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less than 5. The
minimum expected count is .67.
a. 
 
 
 
 
 
 
Group * Connective tissue - Subepithelial - Fibroblasts 
Crosstab
3 1 1 5
60.0% 20.0% 20.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
4 2 9 15
26.7% 13.3% 60.0% 100.0%
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
C 
S
L
Group 
Total 
Wavy Bundles Haphazard
CT - Subep - Pattern
Total
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Crosstab
4 1 5
80.0% 20.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
11 4 15
73.3% 26.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
L
Group
Total
+ ++
CT - Subep -
Fibroblasts
Total
 
Chi-Square Tests
.682a 2 .711
.659 2 .719
.023 1 .880
15
Pearson Chi-Sq
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less
minimum expected count is 1.33.
a. 
 
Group * Connective tissue - Subepithelial - Inflammatory 
Crosstab
3 2 5
60.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
3 7 1 4 15
20.0% 46.7% 6.7% 26.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
L
Group
Total
- + ++ +++
CT - Subep - Inflammatory
Total
 
Chi-Square Tests
18.000a 6 .006
19.579 6 .003
9.852 1 .002
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (100.0%) have expected count less than 5. The
minimum expected count is .33.
a. 
 
Group * Connective tissue - Subepithelial - Hyalinization 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
15 15
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
L
Group
Total
Negative
CT -
Subep -
Hyalinisat
ion
Total
  
Chi-Square Tests
.a
15
Pearson Chi-Square
N of Valid Cases
Value
No statistics are computed because CT
- Subep - Hyalinisation is a constant.
a. 
 
 
 
Group * Connective tissue - Subepithelial - Vascularity 
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Crosstab
3 2 5
60.0% 40.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
2 2 1 5
40.0% 40.0% 20.0% 100.0%
7 7 1 15
46.7% 46.7% 6.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
L
Group
Total
+ ++ +++
CT - Subep - Vascularity
Total
 
Chi-Square Tests
2.571a 4 .632
2.747 4 .601
.964 1 .326
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less than 5. The
minimum expected count is .33.
a. 
 
Group * Connective tissue - Deep - Density 
Crosstab
1 2 2 5
20.0% 40.0% 40.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
7 6 2 15
46.7% 40.0% 13.3% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
L
Group
Total
+ ++ +++
CT - Deep - Dentity
Total
 
Chi-Square Tests
7.000a 4 .136
7.442 4 .114
4.400 1 .036
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less than 5. The
minimum expected count is .67.
a. 
 
 
 
 
Group * Connective tissue - Deep - Pattern 
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Chi-Square Tests
5.250a 4 .263
6.279 4 .179
1.207 1 .272
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.00.
a. 
 
Group * Connective tissue - Deep - Fibroblasts 
Crosstab
4 1 5
80.0% 20.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
14 1 15
93.3% 6.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
L
Group
Total
+ ++
CT - Deep -
Fibroblasts
Total
 
Chi-Square Tests
2.143a 2 .343
2.344 2 .310
1.143 1 .285
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less than 5. The
minimum expected count is .33.
a. 
 
 
 
 
 
 
 
 
Group * Connective tissue - Deep - Inflammatory 
Crosstab
1 3 1 5
20.0% 60.0% 20.0% 100.0%
1 1 3 5
20.0% 20.0% 60.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
3 4 8 15
20.0% 26.7% 53.3% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C 
S 
L
Group
Total
Wavy Bundles Haphazard
CT - Deep - Pattern
Total
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Crosstab
3 2 5
60.0% 40.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
3 1 1 5
60.0% 20.0% 20.0% 100.0%
4 9 1 1 15
26.7% 60.0% 6.7% 6.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
L
Group
Total
- + ++ +++
CT - Deep - Inflammatory
Total
 
Chi-Square Tests
8.167a 6 .226
9.364 6 .154
5.851 1 .016
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (100.0%) have expected count less than 5. The
minimum expected count is .33.
a. 
 
Group * Connective tissue - Deep - Hyalinization 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
15 15
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
L
Group
Total
Negative
CT -
Deep -
Hyalinisat
ion
Total
 
Chi-Square Tests
.a
15
Pearson Chi-Square
N of Valid Cases
Value
No statistics are computed because CT
- Deep - Hyalinisation is a constant.
a. 
 
 
 
 
Group * Connective tissue - Deep - Vascularity 
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Crosstab
2 3 5
40.0% 60.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
3 1 1 5
60.0% 20.0% 20.0% 100.0%
8 6 1 15
53.3% 40.0% 6.7% 100.0%
Count
% within Grou
Count
% within Grou
Count
% within Grou
Count
% within Grou
C
S
L
Group
Total
+ ++ +++
CT - Deep - Vascularity
Total
Chi-Square Tests
3.250a 4 .517
3.506 4 .477
.012 1 .914
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less than 5. The
minimum expected count is .33.
a. 
 
Group * Dysplasia 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 10 15
33.3% 66.7% 100.0%
Count
% within Gro
Count
% within Gro
Count
% within Gro
Count
% within Gro
C
S
L
Group
Total
+ -
Dysplatia
Total
 
Chi-Square Tests
15.000a 2 .001
19.095 2 .000
12.500 1 .000
15
Pearson Chi-Squa
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less tha
minimum expected count is 1.67.
a. 
 
 
Group * Malignant Islands 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
15 15
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
L
Group
Total
-
Malignant
Islands
Total
 
Chi-Square Tests
.a
15
Pearson Chi-Square
N of Valid Cases
Value
No statistics are computed because
Malignant Islands is a constant.
a. 
 
 
 
Group * Homogenous / Lysis 
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Crosstab
5 5
100.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
10 5 15
66.7% 33.3% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
L
Group
Total
H L
Homogenous / Lysis
Total
 
Chi-Square Tests
4.200a 2 .122
5.635 2 .060
.980 1 .322
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.67.
a. 
 
Group * Vangieson 
Crosstab
1 4 5
20.0% 80.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
2 12 1 15
13.3% 80.0% 6.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
S
L
Group
Total
+ ++ +++
Vangieson
Total
 
Chi-Square Tests
3.000a 4 .558
3.819 4 .431
.091 1 .763
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less than 5. The
minimum expected count is .33.
a. 
 
 
 
 
 
 
 
Comparison between Controls, Pan chewers and Sub mucous fibrosis: 
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Group * Keratinization 
Crosstab
2 3 5
40.0% 60.0% 100.0%
5 5
100.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
5 10 15
33.3% 66.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
P
F
Group
Total
O P
Keratinisation
Total
 
Chi-Square Tests
4.200a 2 .122
5.635 2 .060
.420 1 .517
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.67.
a. 
 
Group * Thickness 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 10 15
33.3% 66.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
P
F
Group
Total
A H
Thickness
Total
 
Chi-Square Tests
15.000a 2 .001
19.095 2 .000
10.500 1 .001
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.67.
a. 
 
Group * Interface 
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Crosstab
3 2 5
60.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
5 5
100.0% 100.0%
12 3 15
80.0% 20.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
P
F
Group
Total
N T
Interface
Total
 
Chi-Square Tests
2.500a 2 .287
3.278 2 .194
2.333 1 .127
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.00.
a. 
 
Group * Connective tissue - Subepithelial - Density 
Crosstab
1 3 1 5
20.0% 60.0% 20.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
5 9 1 15
33.3% 60.0% 6.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
P
F
Group
Total
+ ++ +++
CT - Subep - Dentity
Total
 
Chi-Square Tests
2.400a 4 .663
2.634 4 .621
1.135 1 .287
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less than 5. The
minimum expected count is .33.
a. 
 
 
Group * Connective tissue - Subepithelial - Pattern 
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Chi-Square Tests
13.500a 6 .036
16.323 6 .012
7.178 1 .007
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (100.0%) have expected count less than 5. The
minimum expected count is .33.
a. 
 
Group * Connective tissue - Subepithelial - Fibroblasts 
Crosstab
4 1 5
80.0% 20.0% 100.0%
5 5
100.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
13 2 15
86.7% 13.3% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
P
F
Group
Total
+ ++
CT - Subep -
Fibroblasts
Total
 
Chi-Square Tests
1.154a 2 .562
1.772 2 .412
.000 1 1.000
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less than 5. The
minimum expected count is .67.
a. 
 
Group * Connective tissue - Subepithelial - Inflammatory 
Crosstab
3 1 1 5
60.0% 20.0% 20.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
6 1 4 4 15
40.0% 6.7% 26.7% 26.7% 100.0%
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
C 
P 
F
Group 
Total
Wavy Bundles Haphazard Parallel 
CT - Subep - Pattern
Total
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Crosstab
3 2 5
60.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
3 9 3 15
20.0% 60.0% 20.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
P
F
Group
Total
- + ++
CT - Subep - Inflammatory
Total
 
Chi-Square Tests
8.667a 4 .070
10.044 4 .040
5.833 1 .016
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.00.
a. 
 
Group * Connective tissue - Subepithelial - Hyalinization 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
3 12 15
20.0% 80.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
P
F
Group
Total
Present Negative
CT - Subep -
Hyalinisation
Total
 
Chi-Square Tests
7.500a 2 .024
8.282 2 .016
5.250 1 .022
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.00.
a. 
 
Group * Connective tissue - Subepithelial - Vascularity 
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Crosstab
3 2 5
60.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
11 4 15
73.3% 26.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
P
F
Group
Total
+ ++
CT - Subep -
Vascularity
Total
 
Chi-Square Tests
.682a 2 .711
.659 2 .719
.477 1 .490
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.33.
a. 
 
Group * Connective tissue - Deep - Density 
Crosstab
1 2 2 5
20.0% 40.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
2 3 5
40.0% 60.0% 100.0%
7 6 2 15
46.7% 40.0% 13.3% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
P
F
Group
Total
+ ++ +++
CT - Deep - Dentity
Total
 
Chi-Square Tests
7.000a 4 .136
7.442 4 .114
1.718 1 .190
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less than 5. The
minimum expected count is .67.
a. 
 
Group * Connective tissue - Deep - Pattern 
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Chi-Square Tests
12.750a 4 .013
14.056 4 .007
3.201 1 .074
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less than 5. The
minimum expected count is 1.00.
a. 
 
Group * Connective tissue - Deep - Fibroblasts 
Crosstab
4 1 5
80.0% 20.0% 100.0%
5 5
100.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
13 2 15
86.7% 13.3% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
P
F
Group
Total
+ ++
CT - Deep -
Fibroblasts
Total
 
Chi-Square Tests
1.154a 2 .562
1.772 2 .412
.000 1 1.000
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less than 5. The
minimum expected count is .67.
a. 
 
 
Group * Connective tissue - Deep - Inflammatory 
Crosstab
1 3 1 5 
20.0% 60.0% 20.0% 100.0% 
3 2 5 
60.0% 40.0% 100.0% 
5 5 
100.0% 100.0% 
4 3 8 15 
26.7% 20.0% 53.3% 100.0% 
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
Count 
% within Group 
C 
P 
F
Group 
Total
Wavy Bundles Haphazard
CT - Deep - Pattern
Total 
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Crosstab
3 2 5
60.0% 40.0% 100.0%
1 3 1 5
20.0% 60.0% 20.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
3 6 5 1 15
20.0% 40.0% 33.3% 6.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
P
F
Group
Total
- + ++ +++
CT - Deep - Inflammatory
Total
 
Chi-Square Tests
11.800a 6 .067
14.091 6 .029
3.201 1 .074
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
12 cells (100.0%) have expected count less than 5. The
minimum expected count is .33.
a. 
 
Group * Connective tissue - Deep - Hyalinization 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
15 15
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
P
F
Group
Total
Negative
CT -
Deep -
Hyalinisat
ion
Total
 
Chi-Square Tests
.a
15
Pearson Chi-Square
N of Valid Cases
Value
No statistics are computed because CT
- Deep - Hyalinisation is a constant.
a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Group * CT - Deep - Vascularity 
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Crosstab
2 3 5
40.0% 60.0% 100.0%
3 2 5
60.0% 40.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
9 6 15
60.0% 40.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
P
F
Group
Total
+ ++
CT - Deep - Vascularity
Total
 
Chi-Square Tests
1.667a 2 .435
1.726 2 .422
1.556 1 .212
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less than 5. The
minimum expected count is 2.00.
a. 
 
Group * Dysplasia 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
15 15
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
P
F
Group
Total
-
Dysplatia
Total
 
Chi-Square Tests
.a
15
Pearson Chi-Squa
N of Valid Cases
Value
No statistics are computed
because Dysplatia is a consta
a. 
 
Group * Malignant Islands 
Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
5 5
100.0% 100.0%
15 15
100.0% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
P
F
Group
Total
-
Malignant
Islands
Total
 
Chi-Square Tests
.a
15
Pearson Chi-Squ
N of Valid Cases
Value
No statistics are computed bec
Malignant Islands is a constan
a. 
 
 
Group * Homogenous / Lysis 
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Crosstab
5 5
100.0% 100.0%
5 5
100.0% 100.0%
4 1 5
80.0% 20.0% 100.0%
14 1 15
93.3% 6.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
P
F
Group
Total
H L
Homogenous / Lysis
Total
 
Chi-Square Tests
2.143a 2 .343
2.344 2 .310
1.500 1 .221
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
6 cells (100.0%) have expected count less than 5. The
minimum expected count is .33.
a. 
 
Group * Vangieson 
Crosstab
1 4 5
20.0% 80.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
1 4 5
20.0% 80.0% 100.0%
2 9 4 15
13.3% 60.0% 26.7% 100.0%
Count
% within Group
Count
% within Group
Count
% within Group
Count
% within Group
C
P
F
Group
Total
+ ++ +++
Vangieson
Total
 
Chi-Square Tests
11.000a 4 .027
12.816 4 .012
6.105 1 .013
15
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
9 cells (100.0%) have expected count less than 5. The
minimum expected count is .67.
a. 
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RESULTS OF AUTOFLUORESCENCE: (AVERAGED EMISSION AND EXCITATION 
SPECTRUM) 
 
MEAN, STANDARD DEVIATION AND TEST OF SIGNIFICANCE OF MEAN VALUES BETWEEN 
DIFFERENT GROUPS FOR INTENSITY 380nm AT 320nm EXCITATION 
 
GROUP In_380 
Mean ± SD 
P- Value Significant 
Groups  
I 1490616 ± 1.22   
II 1267554 ± 1.16   
III 179225 ± 1.53 < 0.001(sig.) I Vs III 
II Vs III 
Table-1: Mean values in group I (1490616 ± 1.22) and group II (1267554 ± 1.16) are significantly 
higher than the mean value in group III (179225 ± 1.53) with P-Value less than 0.001. However 
there is no significant difference in mean values between groups I and II (P > O.O5). 
 
MEAN, STANDARD DEVIATION AND TEST OF SIGNIFICANCE OF MEAN VALUES BETWEEN 
DIFFERENT GROUPS FOR INTENSITY 420nm AT 320nm EXCITATION 
 
GROUP In_420 
Mean ± SD 
P- Value Significant 
Groups  
I 1411410 ± 1.23   
II 1272126 ± 1.19   
III 176398± 1.44 < 0.001(sig.) I Vs III 
II Vs III 
Table-2: Mean values in group I (1411410 ± 1.23) and group II (1272126 ± 1.19) are significantly 
higher than the mean value in group III (176398 ± 1.44) with P-Value less than 0.001. However 
there is no significant difference in mean values between groups I and II (P > 0.005). 
 
MEAN, STANDARD DEVIATION AND TEST OF SIGNIFICANCE OF MEAN VALUES BETWEEN 
DIFFERENT GROUPS FOR INTENSITY 460nm AT 320nm EXCITATION 
 
GROUP In_460 
Mean ± SD 
P- Value Significant 
Groups  
I 1509969 ± 1.18   
II 1351600 ± 1.22   
III 184444± 1.37 < 0.001(sig.) I Vs III 
II Vs III 
Table-3: Mean values in group I (1509969 ± 1.23) and group II (1351600 ± 1.22) are significantly 
higher than the mean value in group III (184444 ± 1.37) with P-Value less than 0.001. However 
there is no significant difference in mean values between groups I and II (P > 0.005). 
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RESULTS OF AUTOFLUORESCENCE: (AVERAGED EMISSION AND 
EXCITATION SPECTRUM) 
In the present study, native fluorescence spectroscopy of normal mucosa, 
mucosa of pan chewers and tobacco smokers were recorded. For the normal 
individuals and tobacco smokers, readings were taken from the area adjacent 
to second premolar at occlusal level. In case of pan chewers, readings were 
taken from mucosa where the quid was placed.  
The fluorescence spectra were recorded at these sites, at different 
wavelengths corresponding to these native fluorophores present in cells and 
extracellular matrix, such as tryptophan, collagen, elastin and NADH. 
Fluorescence emission spectra of oral mucosa at 280nm excitation: 
(Absorption maximum for tryptophan) 
The average emission spectrum of the normal mucosa, mucosa of pan 
chewers and tobacco smokers, at 280nm excitation corresponding to the amino 
acid residue, tryptophan molecules are shown in fig 33, with wavelength in the 
x-axis and fluorescence intensity in Y- axis.  
Normal oral mucosa and pan chewer’s mucosa showed a prominent peak 
at 338nm and a small peak at 440nm. It is worth to mention that the emission 
at 280nm mostly is due to tryptophan, as the emission efficiency (quantum 
yield) of other two amino acids, phenyl alanine and tyrosine is very minimal as 
that of tryptophan. 
 Mucosa of smokers did not show any peaks at 338nm and 440nm.  
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Normalized emission spectra of oral mucosa at 280nm excitation: 
In order to overcome the artefacts of instruments, tissue heterogeneity, 
normalization of spectra was performed in relation to, either its peak 
wavelength or any wavelength of interest. 
The normalized emission spectra of normal mucosa, mucosa of pan 
chewers and tobacco smokers at 280nm excitation are shown in fig.34. The 
normalized spectrum of normal mucosa, mucosa of pan chewers and tobacco 
smokers showed maximum emission intensity at 340nm wave length. 
It is worth noting that the normal tissues showed a lesser intensity than 
pan chewers and tobacco smokers, at higher wavelengths (400-500nm).   
It clearly indicates that NADH/NAD(P)H and collagen distribution may 
be altered under various tissue transformation conditions. 
Fluorescence emission spectra of oral mucosa at 320nm excitation 
(Absorption spectrum for collagen): 
The average emission spectrum of the normal mucosa, mucosa of pan 
chewers and mucosa of tobacco smokers, at 320nm excitation corresponding to 
the collagen/elastin are shown in fig 35.  
The emission spectra corresponding to normal mucosa and pan chewer’s 
mucosa showed two prominent peaks at 390nm and 460nm respectively. The 
first peak which is at 390nm corresponds to the collagen intensity (around 390) 
and the second peak corresponds to the NADH (around 460nm), which are 
almost equal. 
 However, surprisingly the mucosa of tobacco smokers did not show any 
increase in intensity at 390nm which corresponds to the amount of collagen. 
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The second peak at 460nm which corresponds to NADH in the tissues was also 
not seen in tobacco smokers. 
Normalized emission spectra of oral mucosa at 320nm excitation: 
The normalized emission spectra of normal mucosa, mucosa of pan 
chewers and tobacco smoker’s mucosa at 320nm excitation are shown in fig.36. 
All the three spectra i.e., normal patients, pan chewers and tobacco smokers 
showed maximum emission at 390nm wavelength. A second peak of increased 
wavelength is observed at 451nm for normal, 452nm for pan chewers and 
439nm for tobacco smokers was observed.  
Fluorescence excitation (absorption) spectra of oral mucosa at 
340nm emission: 
The average excitation spectra of the normal mucosa, mucosa of pan 
chewers and mucosa of tobacco smokers, at 340nm emission corresponding to 
the tryptophan are shown in fig 37.  
The emission spectra corresponding to normal mucosa showed 
prominent intensity at 295nm whereas the pan chewer’s mucosa showed a 
prominent peak at 296nm. Tobacco smoker’s mucosa showed a small peak, with 
maximum intensity at 292nm wavelength. This picture shows that the 
maximum intensity is shown by the normal individuals followed by pan 
chewers which showed a slightly decreased intensity compared to the normal 
individuals.  
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Normalized excitation spectra of oral mucosa at 340nm emission: 
The normalized excitation spectra of normal mucosa, mucosa of pan 
chewers and mucosa of tobacco smokers at 340nm emission are shown in 
fig.38.  
Pan chewers did not show significant peak shift compared to the normal 
individuals, both of them is showing maximum intensity at 295nm. 
Surprisingly, patients who are tobacco smokers showed maximum intensity at 
292nm showing a shift to the left i.e., towards shorter wavelength. This shift to 
the left could probably attributed to any conformational changes in the tissue 
protein sequences and/or partial folding of protein structures. 
Fluorescence excitation spectra of oral mucosa at 390nm emission: 
The average excitation spectra of the normal mucosa, mucosa of pan 
chewers and mucosa of tobacco smokers, at 390nm excitation corresponding to 
the collagen are shown in fig 39.  
The excitation spectra corresponding to normal mucosa and pan chewers 
mucosa showed relatively a prominent peak at 295nm, where as tobacco 
smokers showed a small peak at the same wavelength. However, it is worth to 
note that the excitation intensity of pan chewers is much less compared to 
normal at this emission spectrum.  
Normalized excitation spectra of oral mucosa at 390nm emission: 
The normalized emission spectra of normal mucosa, mucosa of pan 
chewers and tobacco smokers at 390nm emission are shown in fig.40. The 
emission spectral findings at 390nm are similar to that of 340nm emission. 
However a slight shift to the left (towards shorter wavelength) is seen in case of 
 127
pan chewers when compared to the normal individuals. Patients who are 
tobacco smokers showed a gross shift to the left as seen in 340nm emission. The 
maximum intensity values at this emission spectrum for normal, pan chewers 
and oral submucous fibrosis are 298, 297 and 294 respectively. This clearly 
indicates that the absorption bands of collagen vary with tissue conditions. 
DISCRIMINATION OF TOBACCO SMOKERS FROM NORMAL 
INDIVIDUALS: 
 As there is considerable difference in the autofluorescence spectra 
between healthy and tobacco smokers, an attempt is also made to verify the 
diagnostic potentiality of this technique. We also attempted to discriminate the 
betel quid chewers from normal patients and tobacco smokers from betel quid 
chewers.  
In this context, different intensity values for excitation 320nm were 
introduced. Among various excitation wavelengths, the intensity values at 380, 
420 and 460 at 320nm excitation were selected for subsequent analysis, as they 
showed considerable differences between normal and tobacco smokers.  
DISCRIMINATION USING PEAK INTENSITY VALUE: 
Figure 41 shows the fluorescence intensity at 380nm for normal and pan 
chewers at 320nm excitation. From the figure, it is observed that there is 
considerable overlap in the fluorescence intensity at I-380 between normal and 
pan chewers. It is also observed that this intensity value discriminates normal 
from betel quid chewers with a sensitivity of 78% and specificity of 12%. 
Figure 42 shows the fluorescence intensity at 380nm for pan chewers 
and tobacco smokers at 320nm excitation. From the figure, it is observed that 
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there is considerable difference in the fluorescence intensity at I-380 between 
pan chewers and tobacco smokers. It is also observed that this intensity value 
discriminates normal from tobacco smokers with a sensitivity of 100% and 
specificity of 100%. 
Figure 43 shows the fluorescence intensity at 380nm for pan chewers 
and tobacco smokers at 320nm excitation. From the figure, it is observed that 
there is considerable difference in the fluorescence intensity at I-380 between 
pan chewers and tobacco smokers. From the figure, it is observed that this 
intensity value discriminates tobacco smokers from pan chewers with a 
sensitivity of 100% and specificity of 100%. 
The Mean, Standard deviation and test of significance of mean 
values between different groups for intensity-380 nm at 320 nm 
excitation shows that the Mean values in group I (1490616 ± 1.22) and group 
II (1267554 ± 1.16) are significantly higher than the mean value in group III 
(179225 ± 1.53) with a p-value of less than 0.001. However there is no 
significant difference in mean values between groups I and II (P >0.05) (Table-
1). 
The Mean, Standard deviation and test of significance of mean 
values between different groups for intensity-420 nm at 320 nm 
excitation shows that the mean values in group I (1411410 ± 1.23) and group II 
(1272126 ± 1.19) are significantly higher than the mean value in group III 
(176398 ± 1.44) with a p-value of less than 0.001. However there is no 
significant difference in mean values between groups I and II (P > 0.05). 
(Table-2) 
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The Mean, Standard deviation and test of significance of mean 
values between different groups for intensity-460 nm at 320 nm 
excitation shows that the Mean values in group I (1509969 ± 1.23) and group 
II (1351600 ± 1.22) are significantly higher than the mean value in group III 
(184444 ± 1.37) with a p-value of less than 0.001. However there is no 
significant difference in mean values between groups I and II (P > 0.005). 
(Table-3) 
RESULTS OF HISTOPATHOLOGICAL ASSESSMENT: 
 Histopathological assessment was performed and the following 
combinations were assessed for statistical significance, 
1. Comparison among the pan chewers, smokers and non-users of 
tobacco. 
2. Comparison among the pan chewers, smokers, non-users of tobacco, 
leukoplakia, sub mucous fibrosis, well differentiated squamous cell 
carcinoma, moderately differentiated squamous cell carcinoma and 
verrucous carcinoma. 
3.  Comparison among the pan chewers, smokers, non-users of tobacco, 
leukoplakia and sub mucous fibrosis. 
4. Comparison among the smokers, non-users of tobacco and 
leukoplakia. 
5. Comparison among the pan chewers, non-users of tobacco and sub 
mucous fibrosis. 
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Comparison among the pan chewers, smokers and non-users of 
tobacco: 
1. Presence of inflammatory cells in the deeper region of the 
connective tissue (p=0.036) was significant. Among the non-
users of tobacco, 3 cases did not have any inflammatory cells and 2 
cases had mild inflammatory infiltrate. Among the smokers, 1 case 
did not have any inflammatory infiltrate and 4 cases had mild 
inflammatory infiltrate. Among the pan chewers, 1 case had mild 
inflammatory infiltrate, 3 cases had moderate inflammatory 
infiltrate and 1 case had severe inflammatory infiltrate (fig 14). 
2. Presence of lysis in the connective tissue (p=0.024) was 
significant. All the 5 cases of non-users of tobacco and 5 cases of pan 
chewers did not show lysis in the connective tissue. Among smokers, 3 
cases showed lysis and 2 cases did not show any lysis (fig 15). 
3. The other parameters of keratinization of the epithelium, thickness of 
the epithelium, interface between the epithelium and connective 
tissue, density of connective tissue, pattern of connective tissue, 
number of fibroblasts, presence of inflammatory cells, hyalinization 
and amount of vascularity  in the sub-epithelial region, density of 
connective tissue, pattern of connective tissue, number of fibroblasts, 
hyalinization and amount of vascularity  in the deeper region, 
presence of dysplasia, malignant islands and intensity of van Gieson 
stain did not achieve statistical significance. 
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Comparison among the pan chewers, smokers, non-users of tobacco, 
leukoplakia, sub mucous fibrosis, well differentiated squamous cell 
carcinoma, moderately differentiated squamous cell carcinoma and 
verrucous carcinoma: 
1. The nature of the keratinized epithelium (p = o.o34) was 
significant. Among non-users of tobacco, 2 cases had ortho-keratinized 
epithelium and 3 cases had para-keratinized epithelium. Among smokers, 
4 cases had para-keratinized epithelium and 1 case had non-keratinized 
epithelium. Among sub mucous fibrosis, 3 cases had ortho-keratinized 
epithelium and 2 cases had para-keratinized epithelium. All the 
remaining groups had para-keratinized epithelium (fig 2). 
2. The thickness of epithelium (p=0.000) was highly significant. 
All cases of sub-mucous fibrosis had atrophied epithelium. All the 
remaining groups had hyperplastic epithelium. 
3. The nature of the interface between epithelium and connective 
tissue (p= 0.000) was highly significant. Among non users of 
tobacco and smokers, the interface was normal in 3 cases and thickened 
in 2 cases. Among pan chewers and leukoplakia, the interface was 
normal in 4 cases and thickened in one case. The interface was 
discontinuous in all the cases of well differentiated and moderately 
differentiated carcinoma. The interface was normal in all cases of 
verrucous carcinoma (fig 3). 
4. The pattern of sub-epithelial connective (p=0.000) was highly 
significant. Among non-users of tobacco, 3 cases had wavy pattern, 1 
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case had bundles and 1 case had haphazard arrangement. Among 
smokers, 1 case had bundles and 4 cases had haphazard arrangement. 
Among pan chewers, 3 cases had wavy pattern and 2 cases had 
haphazard arrangement. Among leukoplakia, 1 case had wavy pattern 
and 4 cases had haphazard arrangement. Among sub mucous fibrosis, 
the pattern was haphazard in 1 case and parallel in 4 cases. Among well 
differentiated squamous cell carcinoma, 1 case had wavy pattern and 4 
cases had haphazard arrangement. Among moderately differentiated 
squamous cell carcinoma, 3 cases had haphazard arrangement and 2 
cases had a stream pattern. Among verrucous carcinoma, all the 5 cases 
had haphazard arrangement (fig 4). 
5. Presence of sub-epithelial inflammatory cells (p=0.000) is 
highly significant. Among the non-users of tobacco, 3 cases did not 
have any inflammatory cells and 2 cases had mild inflammatory 
infiltrate. Among the smokers and pan chewers, 1 case had moderate 
inflammatory infiltrate and 4 cases had mild inflammatory infiltrate. 
Among leukoplakia, 1 case had mild inflammatory cells and 4 cases had 
severe inflammatory infiltrate. Among sub-mucous fibrosis, 2 cases had 
moderate inflammatory infiltrate and 3 cases had mild inflammatory 
infiltrate. Among well differentiated squamous cell carcinoma, 1 case had 
mild inflammatory infiltrate and 4 cases had severe inflammatory 
infiltrate. Among moderately differentiated squamous cell carcinoma, 1 
case had mild inflammation, 3 cases had moderate and 1 case had severe 
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inflammatory infiltrate. Among verrucous carcinoma, 1 case had 
moderate and 4 cases had severe inflammatory infiltrate (fig 5).  
6. Presence of sub-epithelial hyalinization (0.002) was very 
significant. Among sub mucous fibrosis, 3 cases had hyalinization and 
2 cases did not have hyalinization. All the other groups did not have 
hyalinization (fig 6). 
7. The connective tissue pattern in the deeper region (p=0.004) 
was very significant. Among non-users of tobacco, 1 case had wavy 
pattern, 3 cases had bundles and 1 case had haphazard arrangement. 
Among smokers, 1 case had bundles, 1 case had wavy pattern and 3 cases 
had haphazard arrangement. Among pan chewers, 3 cases had wavy 
pattern and 2 cases had haphazard arrangement. Among leukoplakia, 1 
case had wavy pattern and 4 cases had haphazard arrangement. Among 
sub mucous fibrosis, the pattern was haphazard in 5 cases. Among well 
differentiated squamous cell carcinoma, 1 case had wavy pattern and 4 
cases had haphazard arrangement. Among moderately differentiated 
squamous cell carcinoma, 3 cases had haphazard arrangement and 2 
cases had a stream pattern. Among verrucous carcinoma, all the 5 cases 
had haphazard arrangement (fig 7). 
8. The number of fibroblasts in the deeper region (p=0.016) was 
very significant. Among non-users of tobacco and sub mucous fibrosis, 
4 cases had minimal and 1 case had moderate amount of fibroblasts. 
Among smokers, pan chewers and leukoplakia, 5 cases had minimal 
fibroblasts. Among well differentiated carcinoma, 1 case had minimal 
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and 4 cases had moderate amount of fibroblasts. In moderately 
differentiated carcinoma and verrucous carcinoma, 2 cases had minimal 
and 3 cases had moderate number of fibroblasts (fig 8).  
9. The number of inflammatory cells in the deeper region 
(p=0.002) is highly significant. Among the non-users of tobacco, 3 
cases did not have any inflammatory cells and 2 cases had mild 
inflammatory infiltrate. Among the smokers, 1 case did not have any 
inflammatory cells and 4 cases had mild inflammatory infiltrate. Among 
pan chewers, 3 cases had moderate inflammatory infiltrate, 1 case had 
severe inflammatory infiltrate and 1 case had mild inflammatory 
infiltrate. Among leukoplakia, 3 cases had mild inflammatory cells, 1 case 
had moderate and 1 case had severe inflammatory infiltrate. Among sub-
mucous fibrosis, 2 cases had moderate inflammatory infiltrate and 3 
cases had mild inflammatory infiltrate. Among well differentiated 
squamous cell carcinoma, 1 case had mild inflammatory infiltrate and 4 
cases had severe inflammatory infiltrate. Among moderately 
differentiated squamous cell carcinoma, 4 cases had moderate and 1 case 
had severe inflammatory infiltrate. Among verrucous carcinoma, 1 case 
had mild, 2 cases had moderate and 2 cases had severe inflammatory 
infiltrate (fig 9). 
10. Presence of epithelial dysplasia (p=0.000) was highly 
significant. Dysplasia was not evident among non-users, smokers, pan 
chewers and sub mucous fibrosis. Dysplasia was evident among 
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leukoplakia, well differentiated and moderately differentiated carcinoma 
and verrucous carcinoma (fig 10). 
11.  Presence of malignant islands in connective tissue (p=0.000) 
was highly significant. Malignant islands were absent in non-users, 
smokers, pan chewers, leukoplakia, sub mucous fibrosis and verrucous 
carcinoma. Malignant islands were present in well differentiated and 
moderately differentiated carcinomas (fig 11). 
12. The presence of lysis in the connective tissue (p=0.05) was 
significant. All the 5 cases of non-users of tobacco and 5 cases of pan 
chewers did not show lysis in the connective tissue. Among smokers, 3 
cases showed lysis and 2 cases did not show any lysis. Among 
leukoplakia, 2 cases showed lysis and 3 cases did not show lysis. Among 
sub mucous fibrosis, 1 case showed lysis and 4 cases did not show lysis. 
Among well differentiated carcinoma, 4 cases showed lysis and 1 case did 
not show lysis. Among moderately differentiated carcinoma, 3 cases 
showed lysis and 2 cases did not show lysis. Among verrucous 
carcinoma, 4 cases did not show any lysis and 1 case showed lysis (fig 
12). 
13. The intensity of van Gieson stain (p=0.002) was highly 
significant. Among non-users, pan chewers and leukoplakia, 1 case had 
minimal intensity and 4 cases had moderate intensity. Among smokers, 4 
cases had moderate intensity and 1 case had increased intensity. Among 
sub mucous fibrosis, 1 case had moderate intensity and 4 cases had 
increased intensity. Among well differentiated carcinoma, 2 cases had 
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minimal intensity and 3 cases had moderate intensity. Among 
moderately differentiated carcinoma, 4 cases had minimal intensity and 
1 case had moderate intensity. All the 5 cases of verrucous carcinoma had 
moderate intensity (fig 13). 
14. The other parameters of density of connective tissue, number of 
fibroblasts and amount of vascularity in the sub-epithelial region, 
density of connective tissue, presence of hyalinization and amount of 
vascularity in the deeper region did not achieve statistical significance. 
Comparison among the pan chewers, smokers, non-users of tobacco 
and leukoplakia: 
1. Presence of inflammatory cells in the sub-epithelial region 
(p=0.003) was highly significant. Among the non-users of tobacco, 
3 cases did not have any inflammatory cells and 2 cases had mild 
inflammatory infiltrate. Among the smokers and pan chewers, 1 case had 
moderate inflammatory infiltrate and 4 cases had mild inflammatory 
infiltrate. Among leukoplakia, 1 case had mild inflammatory cells and 4 
cases had severe inflammatory infiltrate (fig 25). 
2. Presence of epithelial dysplasia (p=0.000) was highly 
significant. Dysplasia was not evident among non-users, smokers and 
pan chewers. Dysplasia was evident among leukoplakia (fig 26). 
3. The other parameters of keratinization of the epithelium, thickness of the 
epithelium, interface between the epithelium and connective tissue, 
density of connective tissue, pattern of connective tissue, number of 
fibroblasts, hyalinization and amount of vascularity  in the sub-epithelial 
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region, density of connective tissue, pattern of connective tissue, presence 
of inflammatory cells, number of fibroblasts, hyalinization and amount 
of vascularity in the deeper region, malignant islands, status of 
connective tissue and intensity of van Gieson stain did not achieve 
statistical significance. 
Comparison among the pan chewers, smokers, non-users of tobacco, 
and sub mucous fibrosis: 
1. The thickness of the epithelium (p=0.000) was highly 
significant. All cases of sub-mucous fibrosis had atrophied epithelium. 
All the remaining groups had hyperplastic epithelium (fig 27). 
2. The pattern of connective tissue in the sub-epithelial region 
(p=0.006) was highly significant. Among non-users of tobacco, 3 
cases had wavy pattern, 1 case had bundles and 1 case had haphazard 
arrangement. Among smokers, 1 case had bundles and 4 cases had 
haphazard arrangement. Among pan chewers, 3 cases had wavy pattern 
and 2 cases had haphazard arrangement. Among sub mucous fibrosis, 
the pattern was haphazard in 1 case and parallel in 4 cases (fig 28). 
3. Presence of hyalinization in the sub-epithelial connective 
tissue (p=0.014) was very significant. Among sub mucous fibrosis, 
3 cases had hyalinization and 2 cases did not have hyalinization. All the 
other groups did not have hyalinization (fig 44). 
4. The pattern of connective tissue in the deeper region (p=0.043) 
was significant. Among non-users of tobacco, 1 case had wavy 
pattern, 3 cases had bundles and 1 case had haphazard arrangement. 
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Among smokers, 1 case had bundles, 1 case had wavy pattern and 3 cases 
had haphazard arrangement. Among pan chewers, 3 cases had wavy 
pattern and 2 cases had haphazard arrangement. Among sub mucous 
fibrosis, the pattern was haphazard in 5 cases (fig 29). 
5. Presence of inflammatory cells in the deeper region (p=0.05) 
was significant. Among the non-users of tobacco, 3 cases did not have 
any inflammatory cells and 2 cases had mild inflammatory infiltrate. 
Among the smokers, 1 case did not have any inflammatory cells and 4 
cases had mild inflammatory infiltrate. Among pan chewers, 3 cases had 
moderate inflammatory infiltrate, 1 case had severe inflammatory 
infiltrate and 1 case had mild inflammatory infiltrate. Among sub-
mucous fibrosis, 2 cases had moderate inflammatory infiltrate and 3 
cases had mild inflammatory infiltrate (fig 30). 
6. Presence of lysis (p-0.005) was significant. All the 5 cases of non-
users of tobacco and 5 cases of pan chewers did not show lysis in the 
connective tissue. Among smokers, 3 cases showed lysis and 2 cases did 
not show any lysis. Among sub mucous fibrosis, 1 case showed lysis and 4 
cases did not show lysis (fig 31). 
7. The intensity of van Gieson stain (p=0.048) was significant. 
Among non-users and pan chewers, 1 case had minimal intensity and 4 
cases had moderate intensity. Among smokers, 4 cases had moderate 
intensity and 1 case had increased intensity. Among sub mucous fibrosis, 
1 case had moderate intensity and 4 cases had increased intensity (fig 
32). 
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8. The other parameters of keratinization of the epithelium, interface 
between the epithelium and connective tissue, density of connective 
tissue, number of fibroblasts, number of inflammatory cells and amount 
of vascularity  in the sub-epithelial region, density of connective tissue, 
number of fibroblasts, hyalinization and amount of vascularity in the 
deeper region, epithelial dysplasia and malignant islands did not achieve 
statistical significance. 
Comparison among the smokers, non-users of tobacco and 
leukoplakia: 
1. Presence of sub-epithelial inflammatory cells (p=0.006) was 
highly significant. Among the non-users of tobacco, 3 cases did not 
have any inflammatory cells and 2 cases had mild inflammatory 
infiltrate. Among the smokers, 1 case had moderate inflammatory 
infiltrate and 4 cases had mild inflammatory infiltrate. Among 
leukoplakia, 1 case had mild inflammatory infiltrate and 4 cases had 
severe inflammatory infiltrate (fig 18). 
2. Presence of epithelial dysplasia (p=0.001) was highly 
significant. Dysplasia was not evident among non-users and smokers. 
Dysplasia was evident among leukoplakia (fig 19). 
3. The other parameters of keratinization of the epithelium, thickness of the 
epithelium, interface between the epithelium and connective tissue, 
density of connective tissue, pattern of connective tissue, number of 
fibroblasts, hyalinization and amount of vascularity  in the sub-epithelial 
region, density of connective tissue, pattern of connective tissue, number 
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of fibroblasts, presence of inflammatory cells, hyalinization and amount 
of vascularity in the deeper region, malignant islands, presence of lysis 
and intensity of van Gieson staining did not achieve statistical 
significance. 
Comparison among the pan chewers, non-users of tobacco and sub 
mucous fibrosis: 
1. The thickness of epithelium (p=0.001) was highly significant. 
All cases of sub-mucous fibrosis had atrophied epithelium. All the 
remaining groups had hyperplastic epithelium (fig 20). 
2. The pattern of connective tissue in the sub-epithelial region 
(p=0.036) was significant. Among non-users of tobacco, 3 cases had 
wavy pattern, 1 case had bundles and 1 case had haphazard 
arrangement. Among pan chewers, 3 cases had wavy pattern and 2 cases 
had haphazard arrangement. Among sub mucous fibrosis, the pattern 
was haphazard in 1 case and parallel in 4 cases (fig 21). 
3. Presence of hyalinization in the sub-epithelial connective 
tissue (p=0.024) was significant. Among sub mucous fibrosis, 3 
cases had hyalinization and 2 cases did not have hyalinization. All the 
other groups did not have hyalinization (fig 22). 
4. The pattern of connective tissue in the deeper region (p=0.013) 
was very significant. Among non-users of tobacco, 1 case had wavy 
pattern, 3 cases had bundles and 1 case had haphazard arrangement. 
Among pan chewers, 3 cases had wavy pattern and 2 cases had 
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haphazard arrangement. Among sub mucous fibrosis, the pattern was 
haphazard in 5 cases (fig 23). 
5. The intensity of van Gieson stain (p=0.027) was significant. 
Among non-users and pan chewers, 1 case had minimal intensity and 4 
cases had moderate intensity. Among sub mucous fibrosis, 1 case had 
moderate intensity and 4 cases had increased intensity (fig 24). 
6. The other parameters of keratinization of the epithelium, interface 
between the epithelium and connective tissue, density of connective 
tissue, number of fibroblasts, number of inflammatory cells and amount 
of vascularity  in the sub-epithelial region, density of connective tissue, 
number of fibroblasts, number of inflammatory cells, hyalinization and 
amount of vascularity in the deeper region, epithelial dysplasia, presence 
of lysis and malignant islands did not achieve statistical significance. 
Findings of Transmission electron microscopy: 
 The findings of TEM study of the samples are as follows,  
Controls: 
 Presence of continuous, homogeneous, thick collagen bundles with 
occasional blood vessels and numerous fibroblasts. The fibroblasts are spindle / 
elongated in shape with elongated nucleus, dense chromatin, numerous 
endoplasmic reticulum and extended cisternae.  
Smokers: 
 Presence of numerous discontinuous bundles, few dense granules, There 
are few fibroblasts actively secreting collagen. There are increased bundles of 
collagen. The fibroblasts are elongated to spindle shaped, with elongated 
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nucleus pushed to one end, numerous endoplasmic reticulum, extended 
cisternae, granules filled with proteinaceous material. There is presence of mast 
cells. The collagen bundles show prominent banding. 
Pan chewers: 
 Presence of immature, thin filaments and the banding was not 
prominent. The fibroblasts are epithelioid in shape with a round nucleus, 
prominent nucleolus and endoplasmic reticulum. There is evidence of increased 
cellularity. There is presence of many keratinocytes and few melanocytes with 
melanin granules in the connective tissue. There are highly vacuolated cells with 
vacuoles containing some debris. There is presence of degenerating cells or 
apoptotic cells with damaged organelles, fragmented organelles and apoptotic 
bodies. Presence of few lymphoid cells predominantly granulocytes. 
 Increase in fibers, haphazard arrangement of fibrils and reduced 
cellularity. There is presence of fat cells or fat accumulation with fat globules. 
The fibroblasts are stellate in shape. There is presence of degenerating cells and 
numerous vacant spaces. 
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Discussion 
Tobacco is used in many ways. The most basic difference being between 
those in which tobacco is smoked and those in which unburnt tobacco is 
maintained in contact with the oral mucosa. The relative risk of oral cancer is 
increased between 10 – 15 fold in those who chew tobacco 27. 
 It has been estimated that cancers in tobacco and alcohol users develop 
about 15 years earlier than in people who neither smoke nor drink. Much 
emphasis has been given to precancer and cancer throughout the literature. The 
role of connective tissue has not been given much attention in comparison with 
studies on the epithelium.  
Thus we designed the study to evaluate different parameters with a 
special emphasis on connective tissue using three different tools namely, 
Autofluorescence, Histopathology and Transmission Electron microscopy. 
We therein selected patients who are pan chewers or smokers for the past 
5 years, who however did not have any visible changes in the buccal mucosa for 
the study along with controls. 
The study comprised of 30 subjects, 25 males and 5 females aged between 
25 – 40 years. The control group, who did not use tobacco, comprised of 5 males 
and 5 females. The study group of pan chewers comprised of 10 males who use 
atleast 5 packets a day, for a minimum period of 1 year to a maximum of 5 
years. They predominantly used branded commercial tobacco products. The 
study group of smokers comprised of 10 males who use atleast 5 cigarettes a 
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day for a minimum period of 1year to a maximum of 5 years. They 
predominantly used filter cigarettes. 
The study also compared only the histological changes of the study group 
with leukoplakia, oral sub mucous fibrosis, well differentiated squamous cell 
carcinoma, moderately differentiated squamous cell carcinoma and verrucous 
carcinoma. 
The criteria for the assessment were based on the physical state of 
collagen, overall fibroblastic response and inflammatory response. 
Autofluorescence was the first tool to be used for investigation so as to 
get the maximum representation, if at all there is any change in the connective 
tissue. Autofluorescence is a non-invasive, easily applicable tool for the 
detection of alterations in the structural and chemical composition of cells, 
which may include the presence of diseased tissue. Autofluorescence of tissues is 
produced by several endogenous fluorophores and it comprises of fluorophores 
from the tissue matrix like NADH and FAD. Autofluorescence spectroscopy is 
also useful in guiding the clinician to the optimal location for biopsy and has 
shown promising results for screening purposes. 
The present study is aimed at identifying the mucosal changes on regular 
usage of pan and smoking. The tissue fluorescence (Emission and Excitation 
spectra) were recorded for different fluorophores present in the oral mucosa. 
Because of the inherent fluorescent property of the native fluorophores, tissue 
fluorophores emit fluorescence when excited at particular wavelength. This 
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emission of fluorescence by tissues varies for each molecule, according to the 
wavelength used to excite the tissue. 
Tryptophan shows maximum intensity at 280nm, collagen at 320nm, 
NADH at 340nm and endogenous porphyrin at 405nm excitation. Accordingly, 
autofluorescence spectra were performed corresponding to these wavelengths 
for normal mucosa and mucosa of pan chewers and smokers. 
Chen et al 194 performed invivo autofluorescence spectra at 330nm 
excitation. They showed increased fluorescence intensity at 380nm which 
corresponds to wavelength of collagen, in sub mucous fibrosis when compared 
with controls. 
Tsai et al 195 reported decreased intensity at 380nm and attributed this to 
distortion of fluorescence emission caused by collagen in sub mucous fibrosis. 
The fluorescence characteristics in the present study were analyzed based 
on two procedures, which are 
• Fluorescence emission spectroscopy 
• Fluorescence excitation spectroscopy 
Analysis using Fluorescence emission spectroscopy: 
 With fluorescence emission spectroscopy, we can obtain the exact 
wavelength at which there is maximum fluorescence intensity for each natural 
fluorophores. This technique detects the amount of natural fluorophores present 
in the tissue. So, based on the changes in the spectra of normal fluorophores, we 
can identify the disease process. 
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 In the present study, the averaged fluorescence emission spectrum of 
normal mucosa, mucosa of pan chewers and smokers, at 280nm and 320nm 
excitation wavelengths were performed. 
 The averaged fluorescence emission spectra of normal mucosa, mucosa 
of pan chewers and smokers at 280nm corresponding to the tryptophan 
molecules. The salient features are, 
• Normal oral mucosa and mucosa of pan chewers showed a prominent 
peak at 338nm and a small secondary peak at 440nm. 
• Mucosa of smokers showed a small peak at 338nm without a secondary 
peak at 440nm. 
• The normalized emission spectra of normal mucosa, mucosa of pan 
chewers and smokers at 280nm are same with the maximum intensity at 
338nm. 
Although the normalized spectral signature of smokers is similar to that 
of pan chewers and normal mucosa, the absolute intensity is 8 folds lesser than 
that of normal mucosa. The major peak around 338nm may be attributed to 
tryptophan emission. 
It is confirmed that the tissues at 280nm excitation emit similar 
wavelengths; however the relative distribution of tryptophan molecules and/or 
their sequence is different from histological conditions of the tissue. This 
decrease in tryptophan levels may be attributed to the sparse Cellularity or it 
may also be due to the distortion of fluorescent intensity in smokers. 
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The autofluorescence emission spectra of normal mucosa, mucosa of pan 
chewers and smokers at 320nm excitation corresponding to collagen was 
performed and the salient features are, 
• First peak around 390nm corresponds to emission from collagen 
and elastin 
• Second peak at 460nm corresponds to NADH present in epithelial 
cells of the surface mucosa 
• Valley between the two peaks corresponds to the hemoglobin 
absorption of the tissues. 
• The emission spectra of normal mucosa and pan chewers showed 
two prominent peaks centered at 390nm and 460nm with a valley 
around 420nm. However the relative intensity of emission of pan 
chewers is slightly lower than that of normal individuals. 
• The mucosa of smokers has only one broad peak in the region of 
370nm to 530nm without any dip at 420nm indicating less 
vascularity 
The peak at 390nm corresponds to fluorescence intensity by the collagen 
and elastin present in the tissues. It is surprising to observe that smokers 
displayed decreased fluorescent intensity compared to that of normal mucosa 
and pan chewers at this particular wavelength. This observation is 
contradictory to that of Chen et al 194 who found increased collagen intensity in 
sub mucous fibrosis. However, our results are similar to findings of Tsai et al 195 
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who found a decreased intensity in sub mucous fibrosis when compared with 
controls. 
 The second peak at 440nm corresponds to fluorescence emission of 
NADH present in the epithelial cells. The changes in epithelium may result in 
increased NADH intensity. However, the NADH intensity in pan chewers is 
slightly less compared to that of normal. This might be due to minimal 
scattering caused by collagen that is beginning to accumulate in the submucosa 
of these individuals. In case of smokers, no peak was observed at 440nm, which 
probably could be attributed to the distortion of fluorescence caused by 
collagen. 
 The valley that is observed around 420nm corresponds to hemoglobin 
absorption. The valley indicates the amount of vascularity in the tissues. 
Normal mucosa and pan chewers showed a prominent dip around 420nm. But 
smokers did not show any dip at this wavelength. It is also interesting to note 
that spectral signature of smokers is entirely different from normal and pan 
chewers. The spectral band of normal and pan chewers show a valley around 
420nm and 580nm and this indicates a considerable vascularity in these 
tissues. However the valley at 420nm and 580nm are completely absent in 
smokers indicating minimal vascularity. 
Analysis using fluorescent excitation spectra: 
 This is a complimentary technique which is sensitive to any 
conformational changes that take place during the process of tissue 
transformation. It will provide the changes in absorption band of molecules. 
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Inorder to get the emission spectrum, the molecule of interest should be excited 
at its exact absorption wavelength.  
 Generally it is very difficult to measure absorption spectra of turbid 
media like cells and tissues. Under such conditions, fluorescence excitation 
spectra can indirectly measure the absorption band. The peak emission of the 
fluorophores is monitored at different excitation wavelengths. The maximum 
intensity corresponding to a particular wavelength of excitation is the 
absorption wavelength of the molecule. Hence, we also monitored the 
fluorescence excitation spectra for all the tissues, for their emission at 340nm 
and 390 nm to confirm that the emission at 340nm is due to tryptophan and to 
check whether there is any change in the absorption band, when normal tissues 
undergo various transformations. 
  A shift to the right, i.e. to higher wavelength is seen in case of malignancy 
and is called Red shift. Similarly a shift to the left is also observed in some 
situations and is called Left shift or Blue shift. 
 It is found that normal and pan chewers have similar absorption bands 
at 300nm. However smokers have very minimal absorption (30 times less than 
normal). This may be due to the scattering or reflection of light due to decreased 
blood supply. Though there are many controversies behind the decrease in 
fluorescence, our results correlate with Tsai et al 195 and he attributed the 
decrease in fluorescence in sub mucous fibrosis to the distortion of fluorescence 
caused by excess collagen in the sub mucosa. 
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 The average excitation spectra of normal, mucosa of pan chewers and 
smokers at 340nm emission corresponding to tryptophan reveals, 
• The emission spectra corresponding to normal mucosa showed 
prominent intensity at 295nm 
• Pan chewers mucosa showed a prominent peak at 296nm 
• Smokers mucosa showed a small peak at 292nm 
• In normalized spectra at 340nm, smokers showed a shift to the left 
when compared to the normal. 
The results show the maximum intensity of normal mucosa, followed by 
pan chewers who showed a slightly decreased intensity compared to normal 
and smokers showed the minimum absorption. 
The normalized spectra of smokers show the left shift compared to 
normal indicating that there is a considerable rearrangement in the protein 
sequences of amino acids. 
Liang explained this left shift by photophysical characteristics of 
tryptophan which depends on the micro-environmental conditions. In 
particular, the emission of tryptophan depends upon its solvent polarity. The 
shift to shorter wavelength occurs as the solvents surrounding the tryptophan 
residues decrease. This explanation could be applied to smokers, as there is 
stabilization of collagen, making them less soluble to collagenases when 
compared to normal collagen. Another explanation for the left shift or the 
decrease in tryptophan intensity could be due to the sparse Cellularity in the 
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dense collagenized sub mucosa. Another reason for the decrease in collagen 
fluorescence in spite of having more amounts of collagen and elastin is that 
there may be a reflection of light at the epithelium-connective tissue interface 
without any absorption. This may be due to the change in the refractive index of 
the tissues. 
In order to improve the diagnostic interpretation, different parameters 
were introduced at the emission peak of 320nm excitation. We selected 320nm 
excitation because the presence of fluorophores – collagen, hemoglobin and 
NADH that are altered in smokers. The wavelengths were selected at points 
where maximum intensity of corresponding fluorophores was observed. Based 
on these intensity values, we performed statistical analysis. 
At 320nm excitation, the intensity values at 380nm, 420nm and 460nm 
were selected. They showed significant statistical difference between normal 
and smokers, pan chewers and smokers with p value of less than 0.001. 
However the difference between the normal and pan chewers with p value of 
greater than 0.005. 
The mean intensity was calculated for the study groups. The cut off value 
for normal and smokers had significant difference and is around the intensity of 
700000. The cut off for pan chewers and smokers is also around 700000 with a 
sensitivity and specificity of 100%. The cut off value of 1159216 was detected 
with a sensitivity of 77% and specificity of 11%. 
The intensity values at 420nm followed a similar pattern to 380nm 
values described above. Smokers were differentiated from normal and pan 
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chewers with a sensitivity and specificity of 100%. Normal and pan chewers 
showed considerable overlapping; the cut off value 1239853 had sensitivity of 
72% and specificity of 38%.  
The intensity values at 460nm also followed a similar pattern. Smokers 
were different from normal and pan chewers with a sensitivity and specificity 
of 100%. Normal and pan chewers showed sensitivity of 78% and specificity of 
32% at cut off value of 1293550. 
The present non-invasive in-vivo autofluorescence spectroscopy helps to 
differentiate smokers from normal with a significant difference. However 
further studies with more samples is necessary to identify the exact cause of 
decreased fluorescence in smokers, though we attributed it to the distortion of 
fluorescence as mentioned by Tsai et al 195. The attempt to differentiate pan 
chewers from normal was also successful, since early changes with decreased 
fluorescent intensity compared to normal were noted. 
Subsequently, biopsy samples were taken from the representative site as 
detected by autofluorescence. Only five patients from the each study group 
agreed for biopsy. 
Histological comparison of the study group was compared with 
leukoplakia, sub mucous fibrosis, well differentiated and moderately 
differentiated squamous cell carcinoma and verrucous carcinoma. 
After comparing the histological parameters, the presence of 
inflammatory cells was significant among the pan chewers when compared to 
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other study groups. This correlates to the possibility of increased progression to 
sub mucous fibrosis in pan chewers. 
The dominant factor in the alteration of the mechanism of collagen 
synthesis is inflammation, especially chronic inflammation. The monocytes-
macrophage sub group is now known to be capable of mediating matrix 
synthesis by messenger molecules like chemokines and growth factors and by 
synthesizing or activating degradative enzymes like proteinases and 
glycosidases. Among the growth factors, Transforming Growth Factor Beta 
(TGF-β) has been implicated as a key pro-fibrotic factor. However no growth 
factor or cytokine act in isolation and there is undoubtedly a complex, delicate 
array of interactions between the messenger molecules and their target cells 209. 
Keratinization of mucosal epithelium is believed to be inter-related with 
the inflammatory cell infiltrate. In our study, the samples predominantly 
showed hyper-parakeratinization. 
The epithelial thickness may depend on the tobacco habit and the 
location. An explanation for the epithelial hyperplasia is an adaptive response 
to local irritants to provide a greater degree of protection to the underlying 
connective tissue. 
The collagen fibers were wavy in controls and in most of the pan 
chewers. Considering the amount and nature of collagen in the sub-epithelial 
region and deeper region, the haphazard and thickened arrangement of 
connective tissue seen in smokers along with lysis, correlates with the 
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connective tissue changes seen in the early stages of sub mucous fibrosis, where 
the collagen is thickened and seen as separate bundles 210. 
The connective tissue production is permanent and there is no reversal of 
the condition even after the cessation of the habit. The bulk of the connective 
tissue consists of type I collagen and the formation does not appear to be related 
to excessive proliferation of fibroblasts.  
In fact, smokers and pan chewers showed minimal fibroblasts. It has 
been shown that areca nut extracts suppress rather than stimulate the growth 
of cells in culture. Work done in UK has shown that the fibroblasts in oral sub 
mucous fibrosis are connected to collagen production rather than cell 
proliferation. It has been proposed that fibroblasts are functionally 
heterogeneous and play varied roles in any given normal/ diseased tissue. 
Subsequently, to confirm to our histopathological findings, Transmission 
electron microscopy was done.  
In smokers, Presence of numerous discontinuous bundles, few dense 
granules, There are few fibroblasts actively secreting collagen. There are 
increased bundles of collagen. The fibroblasts are elongated to spindle shaped, 
with elongated nucleus pushed to one end, numerous endoplasmic reticulum, 
extended cisternae, granules filled with proteinaceous material. There is 
presence of mast cells. The collagen bundles show prominent banding. 
Our study also revealed the presence of epithelioid, spindle or elongated 
and stellate shaped fibroblasts in the connective tissue. 
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In accordance with literature, Mollenhauer and Bayreuther 208 described 
three distinct fibroblast cell forms in rat connective tissue that can be identified 
on the basis of their morphology. They can also be distinguished from one 
another by the amount and type of collagen synthesized. 
4. The F1 fibroblast is spindle shaped, highly proliferative and secretes low 
levels of type I and III collagen. 
5. The F2 fibroblast is more epitheloid, less proliferative and synthesizes 
relatively more collagen. 
6. The F3 fibroblast is a large stellate cell and the least proliferative, 
produces four to eight times more types I and III collagen than F1. 
According to these workers, F2 cells sequentially arise from F1 cells and F3 
cells sequentially arise from F2 cells. 
 The lysis and fragmentation of collagen fibres was also considered as one 
of the change especially authenticated as an ultrastructural change in sub 
mucous fibrosis. The collagen fibrils were observed to be fragmented, some of 
them showed frayed and bent ends with apparent partial degeneration into 
amorphous material 28. 
Binnie and Cawson 119 found an excess of fine, immature fibrils and inter-
fibrillar matrix in sub mucous fibrosis. Rajendran et al (1986) also reported 
similar ultra-structural findings in sub mucous fibrosis. 
Thus the ultrastructural changes of increased fibrosis in smokers, is in 
accordance with the findings of autofluorescence and histopathology and these 
changes are comparable to oral sub mucous fibrosis. 
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The response of tissue in relevance to smoking differs from pan chewing.  
In smoking, apart from the tobacco component, heat also acts as an additional 
source of insult and may aid in faster diffusion. The initial response of collagen 
fibres in smoking could be due to the synergistic effect of heat and tobacco. The 
collagen response would prevent the further diffusion, resulting in changes in 
epithelium and may thereby progress to leukoplakia and other changes. 
In pan chewing, diffusion may be slow in comparison to smoking, 
thereby producing an initial, protective inflammatory response. The fibroblasts 
would initially produce collagen as a defensive reaction and subsequent insults 
would result in the morphologic change of fibroblasts and thus progress to sub 
mucous fibrosis. 
Our study showed that smokers had connective tissue changes similar to 
sub mucous fibrosis more than that seen in pan chewers. Literature states that 
sub mucous fibrosis is more prevalent in pan chewers and smokers have 
increased tendency to develop leukoplakia, though both are caused by tobacco 
products. 
Our study suggests that the initial connective tissue changes determine 
the progression of altered mucosa to a pre-cancer or cancer which is related to 
other complex interactions. Further studies are required to evaluate the 
significance of our hypothesis. 
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    SUMMARY AND CONCLUSION 
In the present study the following salient features were found, 
• Although there are many fluorophores in the tissues, only the emission 
characteristics of tryptophan, collagen and NADH provided measurable 
variations. 
• Our results showed distinct difference between normal mucosa and 
smokers. 
• Significant difference was also found between pan chewers and smokers. 
• However, we could also discriminate pan chewers from normal 
individuals. 
• Although we attributed the decreased fluorescence intensity in smokers, 
is probably due to the distortion caused by dense fibrosis as advocated by 
Tsai et al or due to the conformational changes in the collagen molecules, 
further studies are necessary to find the exact reason for the decreased 
fluorescence. 
• The intensity of smokers at 390nm is less when compared to normal and 
pan chewers, correlating with the findings of Tsai et al 195. 
Considering the histopathological parameters, the pattern of the sub-
epithelial connective tissue, the presence of chronic inflammatory cells in the 
sub-epithelial connective tissue and deeper regions of connective tissue, 
presence of lysis of connective tissue was significant. 
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The ultrastructure of the fibroblasts among the study group, revealed the 
presence of epithelioid, spindle or elongated and stellate shaped fibroblasts in 
the connective tissue. 
Our study showed that smokers had connective tissue changes similar to 
sub mucous fibrosis more than that seen in pan chewers.  
Literature states that sub mucous fibrosis is more prevalent in pan 
chewers and smokers have increased tendency to develop leukoplakia, though 
both are caused by tobacco products. 
The initial connective tissue changes could determine the progression of 
altered mucosa to pre-cancer or cancer. This transformation is related to 
complex interactions. A clear elucidation has to be obtained through molecular 
biological studies in the future. 
Further studies are required to evaluate the significance of our 
hypothesis. 
Smoking and pan chewing are preventable habits associated with 
considerable morbidity and mortality. Those who survive the ill-effects suffer 
personal consequences and become a considerable burden on the health care 
system. Even if patients cannot reverse their habits, modifications may reduce 
the risk. The awareness among the patients and the health care provider would 
facilitate early diagnosis of the disease. 
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